Drug Database · Clinicians

Atorvastatin

Brands (233) Avamax, Xantor, Atorgen…Show all
Avamax · Xantor · Atorgen · Avator · Cholecur · Vazi2r · Atorwin · Fredtor · Ftor · Korvast · Lestor · Lipitor · Neostatin · Regi2R · Savtatin · Torvastatin · Trovipri · Vastamel · Atopitar · Atorbella · Atorbet · Atorgard · Atorpel · Atorpro · Atorvast-Natrapharm · Avas · Caliptrol · Cholduce · Choltrol · Corestal · Dystatin · Itorvaz · Lipitrol · Protemax · Ranvast · Retastat · Stadin · Toravas · Adivast · Astat · Astorv · Atocard · Atocure · Atorcura · AtorNav · Atorsaph · Atorvex-10 · Atorvex-20 · Atovas · Atrodipex · Azysna · Bestatin · Brelvastin · Carvast · Crystorvas · Descol · Fedstatin · Fulvast · Gostin-10 · Gostin-20 · Govastin · Lifort · Lolip · Neostat · Onestatin · OP-Ator · Restat · SITIvast-40 · Sydenvast · Tored-20 · Zydusatorva 10 · 2rvaz · Atoget 20 · Ator-10 · Ator-20 · Ator-40 · Atorcad · Atoren · Atorfil 20 · Atorgold-10 · ATORGOLD-20 · Atorgold-40 · Atorgold-80 · Atorgrand-20 · Atorimax-20 · Atorimax-40 · Atorimax-80 · Atorix-20 · Atorlee · Atorlipids 20 · Atorlipids 40 · Atormax · Atormed-10 · Atormed-20 · Atorphil · Atorpina-20 · Atorpina-40 · Atorsaph-40 · Atorsaph-80 · Atorsave-10 · Atorsave-20 · Atorsave-40 · Atorschwartz · Atorschwartz 10 · Atorschwartz 20 · Atorschwartz 80 · Atorseth-40 · Atorsky-20 · Atorstan · Atorvacor-10 · Atorvanov 40 · Atorvanov 80 · Atorvas · Atorvas 40 · Atorvast 20 · Atorvax10 · Atorvax20 · Atorvax40 · Atorvax80 · Atorviq 40 · Atosar-10 · Atosar-20 · Atozan-10 · Atozan-20 · Atozan-40 · Atrhos · Atropen-40 · ATV 10 · ATV 40 · Avarix 20 · Avitor · Bellustat · Cholemev 20 · Cholemev 40 · Choless 20 · Duvaztor-20 · Duvaztor-40 · Eldi-El · Emdistat · Endvastor · Eostatin 80 · Farmavast 20 · Faticon · Florvast · Florvast 80 · Genvazt-20 · Gitor-40 · Globastat-20 · Gostat 10 · Gostat 20 · Gostat-40 · Gotorvast 10 · Gotorvast 20 · Gotorvast 40 · Gotorvast 80 · H-Ator 20 · Khrizstatin 40 · Klotor-S · Koditorz · Lemchole 20 · Lemtor 10 · Lemtor 20 · Lemtor 40 · Lemtor 80 · Lieutenant · Lifetor 10 · Lifetor 20 · Linmervast-20 · Linmervast-40 · Lipend 10 · Lipend 20 · Lipiblac · Lipimize-A 15 · Lipinil · Lipinov 10 · Lipinov 20 · Lipizen-20 · Lipizen-40 · Lipotrim-40 · Madrovas-20 · Mayor 10 · Mayor 20 · Mayor 80 · Mayor-40 · Medivazt-20 · MEVAGARD · Novaztor 20 · Novaztor-40 · Nutor · Orvast · Provas · Q-Tor · Redulip · Retavastatin · Saatin 10 · Saatin 20 · Saatin 40 · Stalip-10 · Stalip-40 · Stalip-80 · Sunvas 10 · Sunvas 20 · Sunvas 40 · Sunvas 80 · Technostat · Technostat-10 · Teniente · TG-Tor · Thor-40 · Tored-10 · Torzen-40 · Torzen-80 · Trazovast · Truvast · Vasator 10 · Vascora 20 · Vascora 40 · Vastacon · Vastalife-10 · Vastalife-20 · Vastalife-40 · Vastanex · VASTATOR · VASTIRED 80 · Vastmed 40 · VAZEMIA · XENTOR · Yorvas-10 · Yorvas-20 · Yorvas-40 · Zanvator · Zydusatorva 20 · Zydusatorva 80

HMG CoA reductase inhibitor; Lipid modifying agent (HMG CoA reductase inhibitor); and others PH FDA category

Rx · Prescription drug458 PH productsPNF-listedPhilHealth GAMOTVAT-exempt (some products) Kidney dosing reviewed
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID a60cc18b-0631-4cf0-b021-9f52224ece65, version date April 15, 2024 (Lipitor · Viatris Specialty LLC). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia LIPITOR is an HMG-CoA reductase inhibitor (statin) indicated
US FDA label
Full indications and usage US FDA label

1 INDICATIONS AND USAGE LIPITOR is indicated:

  • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD
  • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH).
  • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH).
  • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia LIPITOR is an HMG-CoA reductase inhibitor (statin) indicated (1):
  • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD. o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD. o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD.
  • As an adjunct to diet to reduce low-density lipoprotein (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH).
  • As an adjunct to other LDL-C-lowering therapies to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia.
  • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia. o Hypertriglyceridemia.

Contraindications

  • Acute liver failure or decompensated cirrhosis
  • Hypersensitivity to atorvastatin or any excipient
renalcarematters.com, reviewed
Contraindications (US label) US FDA label

4 CONTRAINDICATIONS • Acute liver failure or decompensated cirrhosis [see Warnings and Precautions (5.3)] • Hypersensitivity to atorvastatin or any excipients in LIPITOR. Hypersensitivity reactions, including anaphylaxis, angioneurotic edema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported [see Adverse Reactions (6.2)]. • Acute liver failure or decompensated cirrhosis (4). • Hypersensitivity to atorvastatin or any excipient in LIPITOR (4).

Dosing: Adult

  • Hyperlipidemia and cardiovascular risk reduction: Start 10 or 20 mg once daily (40 mg if LDL-C reduction >45% is needed); range 10 to 80 mg once daily
renalcarematters.com, reviewed
Dosage and administration (US label) US FDA label

  • Take orally once daily with or without food (2.1).
  • Assess LDL-C when clinically appropriate, as early as 4 weeks after initiating LIPITOR, and adjust dosage if necessary (2.1).
  • Adults (2.2): o Recommended starting dosage is 10 or 20 mg once daily; dosage range is 10 mg to 80 mg once daily. o Patients requiring LDL-C reduction >45% may start at 40 mg once daily.
  • Pediatric Patients Aged 10 Years of Age and Older with HeFH: Recommended starting dosage is 10 mg once daily; dosage range is 10 to 20 mg once daily (2.3).
  • Pediatric Patients Aged 10 Years of Age and Older with HoFH: Recommended starting dosage is 10 to 20 mg once daily; dosage range is 10 to 80 mg once daily (2.4).
  • See full prescribing information for LIPITOR dosage modifications due to drug interactions (2.5).
2.1 Important Dosage Information

2.1 Important Dosage Information

  • Take Lipitor orally once daily at any time of the day, with or without food.
  • Assess LDL-C when clinically appropriate, as early as 4 weeks after initiating LIPITOR, and adjust the dosage if necessary.
  • If a dose is missed, advise patients not to take the missed dose and resume with the next scheduled dose.
2.2 Recommended Dosage in Adult Patients

2.2 Recommended Dosage in Adult Patients The recommended starting dosage of LIPITOR is 10 mg to 20 mg once daily. The dosage range is 10 mg to 80 mg once daily. Patients who require reduction in LDL-C greater than 45% may be started at 40 mg once daily.

2.3 Recommended Dosage in Pediatric Patients 10 Years of Age and Older with HeFH

2.3 Recommended Dosage in Pediatric Patients 10 Years of Age and Older with HeFH The recommended starting dosage of LIPITOR is 10 mg once daily. The dosage range is 10 mg to 20 mg once daily.

2.4 Recommended Dosage in Pediatric Patients 10 Years of Age and Older with HoFH

2.4 Recommended Dosage in Pediatric Patients 10 Years of Age and Older with HoFH The recommended starting dosage of LIPITOR is 10 mg to 20 mg once daily. The dosage range is 10 mg to 80 mg once daily.

2.5 Dosage Modifications Due to Drug Interactions

2.5 Dosage Modifications Due to Drug Interactions Concomitant use of LIPITOR with the following drugs requires dosage modification of LIPITOR [see Warnings and Precautions (5.1) and Drug Interactions (7.1)]. Anti-Viral Medications

  • In patients taking saquinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir, fosamprenavir plus ritonavir, elbasvir plus grazoprevir or letermovir, do not exceed LIPITOR 20 mg once daily.
  • In patients taking nelfinavir, do not exceed LIPITOR 40 mg once daily. Select Azole Antifungals or Macrolide Antibiotics
  • In patients taking clarithromycin or itraconazole, do not exceed LIPITOR 20 mg once daily. For additional recommendations regarding concomitant use of LIPITOR with other anti-viral medications, azole antifungals or macrolide antibiotics, see Drug Interactions (7.1).

Dosing: Altered kidney function

Atorvastatin needs no dose adjustment in kidney impairment because kidney disease does not change its blood levels (US label). Kidney impairment is a risk factor for myopathy, so muscle symptoms should be watched.

Kidney function measure: Label makes no band distinction.

Show full dosing details
eGFR ≥60
No adjustment (label).
eGFR 30–59
No adjustment (label). Monitor for myopathy. KDIGO: atorvastatin 20 mg/day is the studied dose in CKD G3a–G5; higher doses not proven safe in CKD.
eGFR 15–29
No adjustment (label). Monitor for myopathy. KDIGO: atorvastatin 20 mg/day is the studied dose in CKD G3a–G5; higher doses not proven safe in CKD.
eGFR <15 (not on dialysis)
No adjustment (label). Monitor for myopathy. KDIGO: atorvastatin 20 mg/day is the studied dose in CKD G3a–G5; higher doses not proven safe in CKD.
Hemodialysis (intermittent)
No dose adjustment (not dialyzed; label). KDIGO: do not start a statin in most patients already on dialysis; continue if already taking one at dialysis initiation.
Peritoneal dialysis
No label adjustment; no PD data.
CRRT
No data in label.
  • Dialyzable? Not expected to be significantly removed by hemodialysis (label).
  • Monitoring Muscle symptoms (myopathy, rhabdomyolysis); renal impairment is a risk factor (label).
Children (kidney dosing)
Show full dosing details
eGFR ≥60
No pediatric kidney data; no change expected (adult label has no kidney adjustment). Specialist input.
eGFR 30–59
No pediatric kidney data; no change expected (adult label has no kidney adjustment). Specialist input.
eGFR 15–29
No pediatric kidney data; no change expected (adult label has no kidney adjustment). Specialist input.
eGFR <15 (not on dialysis)
No pediatric kidney data; no change expected (adult label has no kidney adjustment). Specialist input.
Hemodialysis (intermittent)
No pediatric data.
Peritoneal dialysis
No pediatric data.
CRRT
No pediatric data.

Pediatric eGFR: bedside Schwartz equation, 0.413 × height (cm) / serum creatinine (mg/dL). Weight-based doses should not exceed the adult maximum.

renalcarematters.com guidance, reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 16, 2026. Sources are listed under References. Use with the product's package insert and the patient's current kidney function.

US label text: Renal impairment US FDA label

8.6 Renal Impairment Renal impairment is a risk factor for myopathy and rhabdomyolysis. Monitor all patients with renal impairment for development of myopathy. Renal impairment does not affect the plasma concentrations of LIPITOR, therefore there is no dosage adjustment in patients with renal impairment [see Warnings and Precautions (5.1) and Clinical Pharmacology (12.3)].

Renal Impairment Renal disease has no influence on the plasma concentrations or LDL-C reduction of LIPITOR [see Use in Specific Populations (8.6)]. While studies have not been conducted in patients with end-stage renal disease, hemodialysis is not expected to significantly enhance clearance of LIPITOR since the drug is extensively bound to plasma proteins.

Dosing: Hepatic impairment

8.7 Hepatic Impairment In patients with chronic alcoholic liver disease, plasma concentrations of LIPITOR are markedly increased. Cmax and AUC are each 4-fold greater in patients with Childs-Pugh A disease. Cmax and AUC are approximately 16-fold and 11-fold increased, respectively, in patients with Childs-Pugh B disease. LIPITOR is contraindicated in patients with acute liver failure or decompensated cirrhosis [see Contraindications (4)].

US FDA label

Dosing: Pediatric

Approved ages
Heterozygous familial hypercholesterolemia (HeFH) and homozygous FH (HoFH): 10 years and older. Not established under 10 years or for other hyperlipidemias (label).
Usual dose
HeFH: 10 mg once daily, range 10 to 20 mg. HoFH: 10 to 20 mg once daily, range 10 to 80 mg (label gives fixed doses, not mg/kg).
Maximum dose
HeFH 20 mg/day; HoFH 80 mg/day (label).
Neonates
Neonates: not established.

Kidney dosing in children: see Dosing: Altered kidney function.

renalcarematters.com, reviewed
Pediatric use (US label) US FDA label

8.4 Pediatric Use The safety and effectiveness of LIPITOR as an adjunct to diet to reduce LDL-C have been established pediatric patients 10 years of age and older with HeFH. Use of LIPITOR for this indication is based on a double-blind, placebo-controlled clinical trial in 187 pediatric patients 10 years of age and older with HeFH.

In this limited controlled trial, there was no significant effect on growth or sexual maturation in the males or females or on menstrual cycle length in females. The safety and effectiveness of LIPITOR as an adjunct to other LDL-C-lowering therapies to reduce LDL-C have been established pediatric patients 10 years of age and older with HoFH.

Use of LIPITOR for this indication is based on a trial without a concurrent control group in 8 pediatric patients 10 years of age and older with HoFH [see Clinical Studies (14)]. The safety and effectiveness of LIPITOR have not been established in pediatric patients younger than 10 years of age with HeFH or HoFH, or in pediatric patients with other types of hyperlipidemia (other than HeFH or HoFH).

Dosing: Older adult

Geriatric use (US label) US FDA label

8.5 Geriatric Use Of the total number of LIPITOR-treated patients in clinical trials, 15,813 (40%) were ≥65 years old and 2,800 (7%) were ≥75 years old. No overall differences in safety or effectiveness were observed between these patients and younger patients. Advanced age (≥65 years) is a risk factor for LIPITOR-associated myopathy and rhabdomyolysis.

Dose selection for an elderly patient should be cautious, recognizing the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy and the higher risk of myopathy. Monitor geriatric patients receiving LIPITOR for the increased risk of myopathy [see Warnings and Precautions (5.1) and Clinical Pharmacology (12.3)].

Dosage forms

Philippines

  • Film-coated tablet: 5 mg/10 mg, 10 mg, 20 mg, 40 mg, 80 mg
  • Tablet: 10 mg, 20 mg, 40 mg, 80 mg
  • Fiim-coated tablet: 40 mg
  • Film-coated: 10 mg

Registered products in the Philippines

458 products registered with the Food and Drug Administration (FDA) Philippines list Atorvastatin as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Also registered under: Atorvastation (As Calcium) (2 products). Products registered under these spellings are included in the table and marked.

Verify on PH FDA portal

All registered products458
Philippine FDA-registered products for Atorvastatin
Package insert
2rvazAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 16's, 24's, and 80's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
—
DR-XY44284
Feb 9, 2037
AdivastAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Medhaus Pharma, Incorporated
DR-XY38984
Jan 26, 2031
AdivastAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 24's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Medhaus Pharma, Incorporated
DR-XY38508
Sep 15, 2031
AstatAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Medisure Laboratories Pakistan (Pvt.) LimitedPakistan
Accesspoint International Trading Inc.
DRP-6127
May 5, 2031
AstatAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Medisure Laboratories Pakistan (Pvt.) LimitedPakistan
Accesspoint International Trading Inc.
DRP-6126
Feb 9, 2037
AstorvAtorvastatin(As Calcium)
20 mg Film-Coated TabletBlister Pack x 10's (Box of 100's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
777 Red Pharma Inc.Importer: Philgen Pharmaceuticals Inc.
DRP-2778-05
Jul 14, 2027
AstorvAtorvastatin(As Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
777 Red Pharma Inc.Importer: Philgen Pharmaceuticals Inc.Trader: N.A.
DRP-5224-01
Jun 28, 2027
AtocardAtorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
—
DRP-7663
Jan 22, 2030
AtocardAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 24's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
—
DRP-7804
May 12, 2030
AtocureAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's and 200's); Alu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories, Inc.Philippines
Jaac Healthline Marketing
DRP-6339-10
Sep 11, 2031
AtocureAtorvastatin (as Calcium)
80 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Jaac Healthline Marketing
DRP-6341-09
Sep 11, 2030
Atoget 20Atorvastatin (as calcium)
20 mg Film Coated TabletAlu-Amber PVC Blister pack (Box of 10's)
RxVAT-exempt
Sain Medicaments Pvt. Ltd.India
2MG Incorporated
DRP-18408
Jul 6, 2031
AtopitarAtorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's ( Box of 20's)
RxVAT-exempt
GEOFMAN PHARMACEUTICALSPakistan
SAHAR INTERNATIONAL TRADING INC.
DR-XY33467
Jun 7, 2027
AtopitarAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 20's)
RxVAT-exempt
Geofman PharmaceuticalsPakistan
Sahar International Trading, Inc.
DR-XY35745
Apr 27, 2029
AtopitarAtorvastatin (as calcium)
40 mg Film - Coated TabletAlu/Alu Blister Pack x 10's (Box of 20's)
RxVAT-exempt
Geofman PharmaceuticalsPakistan
Sahar International Trading Inc.
DRP-2623
Oct 14, 2029
Ator-10Atorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Innogen Pharmaceuticals, Inc.
DRP-5614
Mar 19, 2029
Ator-20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Innogen Pharmaceuticals, Inc.
DRP-7120
Mar 19, 2029
Ator-40Atorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 8's Box of 24's
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Innogen Pharmaceuticals, Inc.
DRP-7054
Mar 19, 2029
AtorbellaAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 60's, 90's and 100's)
RxVAT-exempt
Flourish PharmaIndia
Speed Med Pharmaceuticals Inc.Importer: Biophil Medical Equipment and Supplies Trading
DRP-17462
Jun 23, 2031
AtorbellaAtorvastatin (As Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 60's, 90's and 100's)
RxVAT-exempt
Flourish PharmaIndia
Speed Med Pharmaceuticals Inc.Importer: Biophil Medical Equipment and Supplies Trading
DRP-17463
Jun 23, 2031
AtorbellaAtorvastatin (As Calcium)
80 mg Film-Coated TabletAlu/Alu Blister pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Flourish PharmaIndia
Biophil Medical Equipment and Suppies Trading
DRP-17464
May 21, 2031
AtorbetAtorvastatin
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 50’s and 100’s)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Better Option Pharmaceuticals, Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-1721-02
Aug 25, 2029
AtorbetAtorvastatin
20 mg Film-Coated TabletAlu-Alu Blister Pack x 10’s Box of 50’s and 100’s
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Better Option Pharmaceuticals, Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-1720-02
Aug 25, 2029
AtorbetAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10‘s (Box of 50’s & 100’s)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Better Option Pharmaceuticals, Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-2254-01
Mar 12, 2031
AtorcadAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Pharma Dynamic, Inc.
DRP-5155-02
Sep 2, 2028
ATORCURAAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister pack x 10’s (Box of 100’s)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Rvm Pharma & Medical Supplies DistributionImporter: Suhitas Pharmaceuticals Inc.
DRP- 9837-03
Jun 23, 2031
AtorcuraAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100's)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
RVM Pharma & Medical Supplies DistributionImporter: Suhitas Pharmaceuticals Inc.
DRP-2254-07
Jun 9, 2031
AtorenAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Philippine Home Pharmaceuticals
DR-XY44031
Jan 12, 2030
Atorfil 20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Healer’s Lab (Unit II)India
PH Phil Asia Medica Co.Importer: Pharmakon Biotec Inc.
DRP-13973-05
May 26, 2028
AtorgardAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Solvang Pharmaceuticals, Inc.Trader: Dr. Zen’s Research, Inc.
DRP-7550
May 14, 2030
AtorgardAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Solvang Pharmaceuticals, Inc.Trader: Dr. Zen’s Research, Inc.
DRP-8345
Jan 23, 2030
AtorgardAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 24's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Solvang Pharmaceuticals, Inc.Trader: Dr. Zen’s Research, Inc.
DRP-7551
May 12, 2030
AtorgenAtorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 40's (Box of 40's, 120's and 200's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
EBA GENERISCH TRADING INC.
DRP-5880-01
Sep 9, 2029
AtorgenAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Eba Generisch Trading Inc.
DRP-6340-01
Sep 26, 2031
AtorgenAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Eba Generisch Trading Inc.
DRP-6339-01
Sep 22, 2031
AtorgenAtorvastatin (as Calcium)
80 mg Film-Coated TabletAlu PVC Blister Pack x 10's (Box of 30's, 50's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Eba Generisch Trading Inc.
DRP-16342-02
Feb 12, 2030
AtorgenAtorvastatin (as Calcium)
80 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Eba Generisch Trading Inc.
DRP-6341-01
Sep 29, 2031
Atorgold-10Atorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 40's (Box of 40's; 120's and 200's); Alu/Opaque White PVC Blister Pack x 20's (Box of 100's); Alu/Opaque White PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Brilliantmeed, Inc.
DRP-5880-09
Sep 9, 2029
ATORGOLD-20Atorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 20's (Box of 100's and 200's); Alu/Opaque White PVC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Brilliantmeed, Inc.
DRP-6340-09
Sep 11, 2030
Atorgold-40Atorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's and 200's); Alu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories, Inc.Philippines
Brilliantmeed, Inc.
DRP-6339-09
Sep 11, 2030
Atorgold-80Atorvastatin (as Calcium)
80 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's and 200's); Alu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Brilliantmeed, Inc.
DRP-6341-08
Sep 11, 2030
Atorgrand-20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu / Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Healer's Lab (Unit II)India
Grandis Pharma IncorporatedImporter: Pharmakon Biotec Inc.
DRP-13973-04
May 26, 2028
Atorimax-20Atorvastatin Calcium
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Healer's Lab (Unit II)India
Pharmakon Biotec Inc.
DRP-13973
May 26, 2028
Atorimax-40Atorvastatin (as calcium trihydrate)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Healer's Lab (Unit II)India
Pharmakon Biotec Inc.
DRP-15961
Oct 4, 2029
Atorimax-80Atorvastatin (as calcium trihydrate)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Healer's Lab (Unit II)India
Pharmakon Biotec, Inc.
DRP-15046
Jul 3, 2029
Atorix-20Atorvastatin (as calcium trihydrate)
20 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Healer's Lab (Unit II)India
Teramedix Pharma Trading Inc.Trader: Sarva Pharmaceuticals Pvt. Ltd.
DRP-14082
Jun 16, 2028
AtorleeAtorvastatin
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
GMX SolutionsTrader: D.B. Manix International, Inc.
DRP-8366
Dec 17, 2029
Atorlipids 20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-10747-03
Aug 17, 2037
Atorlipids 40Atorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s and 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-3109-11
Jul 12, 2029
AtormaxAtorvastatin (as Calcium)
20mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Flamingo Pharmaceuticals Ltd.India
Excelcare, Inc.Importer: Hexagon Pharmaceuticals
DRP-2383-02
Apr 17, 2029
Atormed-10Atorvastatin (As Calcium Trihydrate)
10mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
ACME Formulations Pvt. Ltd.India
Medinova Pharmaceutical, Inc.
DRP-12225
Jul 12, 2027
Atormed-20Atorvastatin(as Calcium Trihydrate)
20mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
ACME Formulations Pvt. Ltd.India
Medinova Pharmaceutical, Inc.
DRP-12155
Jun 22, 2027
AtorNavAtorvastatin
20 mg Film-Coated TabletClear PVC / Alu foil blister pack x 10's (Box of 100's)
RxVAT-exempt
Scheele Laboratories Phils., Inc.Philippines
JN Carlo Pharmaceuticals
DRP-7530-03
Dec 1, 2027
AtorNavAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu / Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Scheele Laboratories Phils., Inc.Philippines
JN Carlo Pharmaceuticals Distributor
DRP-8593-01
Dec 20, 2029
AtorpelAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu / Opaque White PVC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Errapel Pharmed Corp.
DRP-6340-05
Sep 19, 2031
AtorpelAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Errapel Pharmed Corp.
DRP-6339-05
Oct 20, 2031
AtorpelAtorvastatin (as Calcium)
80 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Errapel Pharmed Corp.
DRP-6341-05
Oct 30, 2031
AtorphilAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Phil Asia Pharma, Inc.Importer: Ambica International Corporation
DRP-3109-02
Jul 12, 2029
Atorpina-20Atorvastatin (as calcium trihydrate)
20 mg Film-Coated TabletAlu-Alu blister pack x 10's (Box of 30's and 60's)
RxVAT-exempt
Pinnacle Life Science Pvt. Ltd.India
Despina Pharma Inc.
DRP-15744
Sep 11, 2029
Atorpina-40Atorvastatin (as calcium trihydrate)
40 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's and 60's)
RxVAT-exempt
Pinnacle Life Science Pvt. Ltd.India
Despina Pharma Inc.
DRP-15743
Sep 11, 2029
AtorproAtorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Transcend Phils., Inc.
DRP-7519
Jan 22, 2030
AtorproAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Transcend Phils., Inc.
DRP-7520
Jan 12, 2030
AtorproAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 24's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Transcend Phils., Inc.
DRP-7521
May 12, 2030
AtorsaphAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 20's); Alu/Clear PVC Blister Pack x 10's (Box of 30's); Alu/Clear PVC Blister Pack x 10's (Box of 60's); Alu/Clear PVC Blister Pack x 10's (Box of 90's); Alu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
SAPPHIRE LIFESCIENCES PVT. LTDIndia
NELPA LIFESCIENCES, INC.
DRP-4470
Jun 13, 2028
AtorsaphAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 20's
RxVAT-exempt
SAPPHIRE LIFESCIENCES PVT. LTDIndia
NELPA LIFESCIENCES, INC.
DRP-5211
Mar 5, 2029
Atorsaph-40Atorvastatin (As Calcium)
40 mg Film-coated TabletAlu Foil Strip x 10's (Box of 100's)
RxVAT-exempt
Sapphire Lifesciences Pvt. LtdIndia
Nelpa Lifesciences, Inc.
DRP-11000
Dec 31, 2026
Atorsaph-80Atorvastatin (as calcium)
80 mg Film-Coated TabletAlu Foil Strip x 10's (Box of 100's)
RxVAT-exempt
Sai Parenterals Ltd.India
Nelpa Lifesciences, Inc.
DRP-10995
Nov 5, 2030
Atorsave-10Atorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Medisky PharmaceuticalsIndia
Savelink Pharma and Trading Co.Importer: Aglobal Care, Inc.
DRP-15640-02
Aug 14, 2029
Atorsave-20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Medisky PharmaceuticalsIndia
Savelink Pharma and Trading Co.Importer: Aglobal Care, Inc.
DRP-15641-01
Aug 14, 2029
Atorsave-40Atorvastatin (as calcium)
40 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Medisky PharmaceuticalsIndia
Savelink Pharma And Trading Co.Importer: Aglobal Care, Inc.
DRP-15543-01
Aug 7, 2029
AtorschwartzAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's); Alu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Medcare PharmaceuticalsImporter: Ambica International CorporationTrader: Endurance Healthcare Pvt. Ltd.
DRP-5137-05
Feb 13, 2029
Atorschwartz 10Atorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Medcare PharmaceuticalsImporter: Ambica International Corporation
DRP-3123-05
Jul 12, 2029
Atorschwartz 20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Medcare PharmaceuticalsImporter: Ambica International Corporation
DRP-4879-07
Nov 7, 2028
Atorschwartz 80Atorvastatin (as calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Medcare PharmaceuticalsImporter: Ambica International Corporation
DRP-10749-06
Nov 15, 2031
Atorseth-40Atorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10‘s (Box of 100’s)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
999 Seth Pharmaceutical Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-2254-05
Mar 15, 2031
Atorsky-20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's and 30's)
RxVAT-exempt
Ratnatris Pharmaceuticals Private LimitedIndia
Skymed Pharma DistributorImporter: Medinova Pharmaceutical Inc
DRP-15714-04
Sep 6, 2029
AtorstanAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack X 8's (Box of 40's)
RxVAT-exempt
J.M. Tolmann Laboratories, Inc.Philippines
Gold Life Distribution Phils. Inc.
DRP-3175-09
Jan 4, 2030
Atorvacor-10Atorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s Box of 100’s
RxVAT-exempt
Akums Drugs & Pharmaceuticals, Inc.India
Diafarm Inc.Trader: Unosource Pharma Limited
DRP-2997
May 26, 2029
Atorvanov 40Atorvastatin (as calcium)
40 mg Film-Coated Tablet
RxVAT-exempt
S Kant Healthcare Ltd.India
Medinova Pharmaceutical Inc.
DRP-17691
Feb 18, 2032
Atorvanov 80Atorvastatin (as calcium)
80 mg Film-Coated Tablet
RxVAT-exempt
S Kant Healthcare Ltd.India
Medinova Pharmaceutical Inc
DRP-17686
Feb 16, 2032
AtorvasAtorvastatin (as Calcium)
20 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 30's)
RxVAT-exempt
Bal Pharma LimitedIndia
Euroasia Pharmaceuticals, Inc.Importer: Pharmakon Biotec Inc.
DRP-5128-01
Feb 12, 2029
Atorvas 40Atorvastatin (as calcium)
40 mg Film coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
EuroAsia Pharmaceuticals, Inc.Trader: Tunic Healthcare
DRP-10107
Apr 21, 2031
Atorvast 20Atorvastatin(As Calcium)
20 mg Film-Coated TabletBlister Pack x 10's (Box of 100's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
The Generics Pharmacy, Inc.Importer: Philgen Pharmaceuticals Inc.
DRP-2778-03
Jul 14, 2027
Atorvast-NatrapharmAtorvastatin (as calcium propylene glycol solvate)
20mg Film-Coated tabletAlu/Alu Blister Pack x 10's Box of 10's; Alu/Alu Blister Pack x 10's Box of 100's
RxVAT-exempt
Apotex, Inc.Canada
Importer: Natrapharm, Inc.
DR-XY40121
Oct 4, 2029
Atorvast-NatrapharmAtorvastatin (as calcium propylene glycol solvate)
40 mg Film-Coated tabletAlu/Alu Blister Pack x 10's (Box of 10's); Alu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Apotex, Inc.Canada
Importer: Natrapharm, Inc.
DR-XY40120
Oct 4, 2029
Atorvast-NatrapharmAtorvastatin (as calcium propylene glycol solvate)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's); Alu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Apotex Inc.Canada
Importer: Natrapharm, Inc.
DR-XY40119
Oct 4, 2029
Atorvax10Atorvastatin (as Calcium Trihydrate)
10 mg Film-Coated TabletAlu-Alu Blister pack x 10's (Box of 100's)
RxVAT-exempt
Globela Pharma Private LimitedIndia
AMB HK Enterprises, Inc.
DRP-18495
Jul 22, 2031
Atorvax20Atorvastatin (as Calcium Trihydrate)
20 mg Film-Coated TabletAlu-Alu Blister pack x 10's (Box of 100's)
RxVAT-exempt
Globela Pharma Pvt. Ltd.India
AMB HK Enterprises, Inc.
DRP-18494
Jul 22, 2031
Atorvax40Atorvastatin (as Calcium Trihydrate)
40 mg Film-Coated TabletAlu-Alu Blister pack x 10's (Box of 100's)
RxVAT-exempt
Globela Pharma Private LimitedIndia
AMB HK Enterprises, Inc.
DRP-18493
Jul 22, 2031
Atorvax80Atorvastatin (as Calcium Trihydrate)
80 mg Film-Coated TabletAlu-Alu Blister pack x 10's (Box of 100's)
RxVAT-exempt
Globela Pharma Private LimitedIndia
AMB HK Enterprises, Inc.
DRP-18491
Jul 22, 2031
Atorvex-10Atorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's and 30's)
RxVAT-exempt
Ratnaris Pharmaceuticals Private LimitedIndia
Reta DrugImporter: Medinova Pharmaceutical Inc.
DRP-15715-01
Sep 5, 2029
Atorvex-10Atorvastatin (as Calcium Trihydrate)
10mg FIlm-CoatedAlu-Alu Blister Pack x 10's (Box of 30's; Box of 100's)
RxVAT-exempt
ACME Formulations Pvt. Ltd.India
Reta DrugImporter: Medinova Pharmaceutical Inc.
DRP-12225-01
Jul 12, 2027
Atorvex-20Atorvastatin (as Calcium Trihydrate)
20 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 30's. Box of 100's)
RxVAT-exempt
Acme Formulation Pvt. Ltd.India
Reta DrugImporter: Medinova Pharmaceutical Inc.
DRP-12155-02
Jun 22, 2027
Atorvex-20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's; Box of 100's)
RxVAT-exempt
Ratnatris Pharmaceuticals Private LimitedIndia
Reta DrugImporter: Medinova Pharmaceutical Inc.
DRP-15714-02
Sep 6, 2029
Atorviq 40Atorvastatin (as calcium trihydrate)
40 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Healer’s Lab (Unit II)India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-15961-06
Oct 4, 2029
AtorwinAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 28's and 30's)
RxVAT-exempt
ZENTIVA, K.S.Czech Republic
Importer: SANOFI-AVENTIS PHILIPPINES, INC
DRP-7946
Aug 8, 2028
AtorwinAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
ZENTIVA, K.S.Czech Republic
Importer: SANOFI-AVENTIS PHILIPPINES, INC
DRP-7947
Aug 8, 2028
AtorwinAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Saneca Pharmaceuticals A.S.Slovakia
Importer: sanofi-aventis Philippines, Inc.
DRP-2492
Sep 27, 2030
AtorwinAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
ZENTIVA, K.S.Czech Republic
Importer: SANOFI-AVENTIS PHILIPPINES, INC
DRP-7948
Aug 8, 2028
Atosar-10Atorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 50’s & 100’s)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Suhitas Pharmaceuticals Inc.
DRP-9838
Jun 23, 2031
Atosar-20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 50’s & 100’s)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Suhitas Pharmaceuticals Inc.
DRP-9837
Jun 23, 2031
AtovasAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Vitalink Health Products, Inc.
DR-XY38983
Jan 26, 2031
AtovasAtorvastatin (as calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 24's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Vitalink Health Products, Inc.
DR-XY37436
Feb 9, 2030
Atozan-10Atorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 40's (Box of 40's, 120's & 200's); Alu/Opaque White PVC Blister Pack x 20's (Box of 100's); Alu/Opaque White PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Triple 888 Medical And Pharma Inc.
DRP-5880-07
Sep 9, 2029
Atozan-20Atorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories, Inc.Philippines
Tripple 888 Medical and Pharma Inc.
DRP-6340-08
Sep 11, 2030
Atozan-40Atorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's and 200's); Alu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories, IncPhilippines
Triple 888 Medical And Pharma Inc.
DRP-6339-07
Sep 11, 2030
AtrhosAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s and 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation
DRP-3109-12
Jul 12, 2029
AtrodipexAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Sapphire Lifesciences Pvt. Ltd.India
Ambitech Biopharmaceuticals Inc.Importer: Nelpa Lifesciences, Inc.
DRP-11000-01
Dec 31, 2026
AtrodipexAtorvastatin (as calcium)
80 mg Film-Coated TabletAlu Foil Strip x 10's (Box of 100's)
RxVAT-exempt
Sapphire Lifesciences Pvt. Ltd.India
Ambitech Biopharmaceuticals Inc.Importer: Nelpa Lifesciences, Inc.
DRP-10995-01
Dec 31, 2026
Atropen-40Atorvastatin (as calcium)
40 mg FiIm-Coated TabletAlu/Alu Blister x 10's (Box of 100's)
RxVAT-exempt
Gpax Pharmaceuticals Private Ltd.India
A. Pendragon International Distribution OpcImporter: Khriz Pharma Trading Inc.
DRP-13270-01
Feb 8, 2028
ATV 10Atorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Delta Pharma Ltd.Bangladesh
Importer: Biomed Pharma Inc.
DR-XY40506
Jan 6, 2027
ATV 40Atorvastatin(calcium)
40 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Delta Pharma Ltd.Bangladesh
Biomed Pharma Inc.
DRP-15970
Oct 7, 2029
AvamaxAtorvastation (as Calcium)Variant spelling
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Amherst Laboratories Inc.Philippines
Trader: UNILAB, Inc.
DR-XY44383
Sep 30, 2029
AvamaxAtorvastatin (As Calcium trihydrate)
10 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 100's)
RxVAT-exempt
PT Darya-Varia Laboratoria, Tbk.Indonesia
UNILAB, Inc.
DRP-12136
Jun 22, 2027
AvamaxAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Ranbaxy (Malaysia) Sdn. Bhd.Malaysia
UNILAB, INC.Importer: Ritemed Phils., Inc.
DRP-1233-02
Feb 2, 2029
AvamaxAtorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 100's
RxVAT-exempt
Lek Pharmaceuticals D.D.Slovenia
Unilab, Inc.Importer: Sandoz Philippines Corporation
DRP-2278-01
Aug 13, 2029
AvamaxAtorvastation (As Calcium)Variant spelling
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Amherst Laboratories IncPhilippines
Trader: UNILAB, Inc.
DR-XY44382
Sep 30, 2029
AvamaxAtorvastatin (As Calcium trihydrate)
20 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 100's)
RxVAT-exempt
PT Darya-Varia Laboratoria, Tbk.Indonesia
UNILAB, Inc.
DRP-12135
Jun 20, 2027
AvamaxAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Ranbaxy (Malaysia) SDN. BHDMalaysia
Unilab, Inc.Importer: Ritemed Phils., Inc.
DRP-1234-02
Feb 2, 2029
AvamaxAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 100's
RxVAT-exempt
Lek Pharmaceuticals D.D.Slovenia
Unilab, Inc.Importer: Sandoz Philippines Corporation
DRP-2272-01
Jul 3, 2029
AvamaxAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Amherst Laboratories IncPhilippines
Trader: UNILAB, Inc.
DR-XY44385
Sep 30, 2029
AvamaxAtorvastatin (As Calcium trihydrate)
40 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 100's)
RxVAT-exempt
PT Darya-Varia Laboratoria, Tbk.Indonesia
UNILAB, Inc.
DRP-12134
Jun 20, 2027
AvamaxAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 100's
RxVAT-exempt
Ranbaxy (Malaysia) SDN. BHDMalaysia
UNILAB, INC.Importer: Ritemed Phils., Inc.
DRP-1232-02
Feb 2, 2029
AvamaxAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lek Pharmaceuticals D.D.Slovenia
Unilab Inc.Importer: Sandoz Philippines Corporation
DRP-2279-02
Aug 13, 2029
AvamaxAtorvastatin (as calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Amherst Laboratories IncPhilippines
Trader: UNILAB, Inc.
DR-XY44384
Sep 30, 2029
AvamaxAtorvastatin (as calcium trihydrate)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lek S.A.Poland
UNILAB, Inc.Importer: Sandoz Philippines Corporation
DRP-15498-01
Jul 29, 2029
AvamaxAtorvastatin (as Calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 5's (Box of 30's)
RxVAT-exempt
Lek Pharmaceuticals D.D.Slovenia
Unilab, Inc.Importer: Sandoz Philippines Corporation
DRP-2273-01
Aug 13, 2029
Avarix 20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Healer’s Lab (Unit II)India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-13973-01
May 26, 2028
AvasAtorvastatin (as Calcium)
10mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 30's
RxVAT-exempt
MICRO LABS LIMITEDIndia
BROWN & BURK PHILIPPINES, INC.
DRP-7057
Oct 17, 2027
AvasAtorvastatin (as Calcium)
20mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Micro Labs LimitedIndia
Brown & Burk Philippines, Inc.
DRP-7056
Oct 2, 2027
AvasAtorvastatin ( as calcium )
40 mg Film Coated TabletAlu/Alu Blister Pack x10's (Box of 30's)
RxVAT-exempt
Micro Labs LimitedIndia
Brown & Burk Philippines Inc.
DRP-9583
Oct 23, 2028
AvatorAtorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 50's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Corbridge Group Phils., Inc.
DR-XY38678
Oct 29, 2031
AvatorAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 50's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Corbridge Group Phils., Inc.
DR-XY38985
Jan 26, 2030
AvatorAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu-Alu Blister Pack x 8's (Box of 48's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Corbridge Group Phils., Inc.
DR-XY38908
Dec 29, 2030
AvatorAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's)
RxVAT-exempt
Agio Pharmaceuticals Ltd.India
Corbridge Group Phils., Inc.Importer: Ambica International Corporation
DRP-4371-02
Apr 11, 2028
AvatorAtorvastatin (as Calcium Trihydrate)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 100's
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Corbridge Group Phils., Inc.Importer: Ambica International Corporation
DRP-4295-02
Mar 13, 2028
AvitorAtorvastatin (as Calcium)
20 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 30's)
RxVAT-exempt
Bal Pharma LimitedIndia
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-5128-05
Feb 12, 2029
AzysnaAtorvastatin (As Calcium Trihydrate)
20 mg Film-Coated TabletAlu-Alu Blister Pack X 10's (Box of 30's)
RxVAT-exempt
Pinnacle Life Science Pvt. Ltd.India
Novocore Pharma Inc.Importer: Despina Pharma Inc.
DRP-15744-02
Sep 11, 2029
AZYSNAAtorvastatin (As Calcium Trihydrate)
40 MG FILM-COATED TABLETAlu-Alu Blister Pack X 10's (Box of 30's)
RxVAT-exempt
Pinnacle Life Science Private LimitedIndia
Novocore Pharma Inc.Importer: Despina Pharma Inc.
DRP-15743-02
Sep 11, 2029
BellustatAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30's)
RxVAT-exempt
Akriti Pharmaceuticals Pvt. Ltd.India
Medhart Pharma Inc.Importer: Aglobal Care, Inc.Trader: PPJ Pharma Pvt. Ltd.
DRP-8059-01
Mar 27, 2027
BestatinAtorvastatin
20 mg Film-Coated TabletAlu-Alu Blister Pack x 10’s Box of 50’s and 100’s
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Littman Drug CorporationImporter: Suhitas Pharmaceuticals Inc.
DRP-1720
Aug 25, 2029
BestatinAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 50’s); Alu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Littman Drug CorporationImporter: Suhitas Pharmaceuticals Inc.
DRP-2254
Feb 9, 2031
BrelvastinAtorvastatin (as Calcium)
20 mg Film-Coated TabletPVC/Alu Blister x 10's (Box of 100's)
RxVAT-exempt
Kausikh Therapeutics (P) Ltd.India
Brel Pharmaceutical Inc.
DRP-4450
Jun 5, 2031
BrelvastinAtorvastatin (as calcium)
40 mg Film-Coated TabletPVC/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Kausikh Therapeutics (P) Ltd.India
Brel Pharmaceutical Inc.
DRP-4640
Aug 29, 2031
CaliptrolAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Strip x 10 Tablets per blister strip = 100 tablets in total per unit carton (Box of 100's)
RxVAT-exempt
Ferozsons Laboratories LimitedPakistan
First Global Trading Corporation
DR-XY43920
Nov 21, 2029
CaliptrolAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Strip x 10's (Box of 100's)
RxVAT-exempt
Ferozsons Laboratories LimitedPakistan
FIRST GLOBAL TRADING CORPORATION
DR-XY43919
Nov 21, 2029
CaliptrolAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Strip x 10 Tablets (Box of 100's)
RxVAT-exempt
Ferozsons Laboratories LimitedPakistan
First Global Trading Corporation
DRP-11781
Nov 21, 2029
CarvastAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Crisdy-Na Drug Corporation
DRP-5155-05
Sep 2, 2028
CarvastAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30's and 100’s)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Crisdy-Na Drug Corporation
DRP-6540-04
Jul 8, 2029
CholduceAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
D&G PharmaImporter: Ambica International CorporationTrader: Endurance Healthcare Ltd.
DRP-4879-04
Nov 7, 2028
CholduceAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 30's
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
D & G PharmaImporter: Ambica International Corporation
DRP-3109-06
Jul 12, 2029
CholduceAtorvastatin (as Calcium Trihydrate)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
D&G PharmaImporter: Ambica International Corporation
DRP-4295-05
Mar 13, 2028
CholecurAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 40's (Box of 40's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-5880-03
Sep 9, 2029
CholecurAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories, Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-6340-03
Sep 11, 2031
CholecurAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-6339-03
Sep 22, 2031
CholecurAtorvastatin (as calcium)
80 mg Film-Coated TabletAlu PVC Blister Pack x 10's (Box of 30's, 50's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-16342-01
Feb 12, 2030
CholecurAtorvastatin (as calcium)
80 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-6341-03
Oct 30, 2031
Cholemev 20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Healer’s Lab (Unit II)India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-13973-02
May 26, 2028
Cholemev 40Atorvastatin (as calcium trihydrate)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of l00's)
RxVAT-exempt
Healer’s Lab (Unit II)India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-15961-01
Oct 4, 2029
Choless 20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's & 100's)
RxVAT-exempt
Healer’s Lab (Unit II)India
Alpha Farmaceutico Corp.Importer: Pharmakon Biotec Inc.
DRP-13973-06
May 26, 2028
CholtrolAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s)
RxVAT-exempt
Agio Pharmaceuticals LimitedIndia
Ambica International Corporation
DRP-2796
Jul 10, 2031
CholtrolAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s)
RxVAT-exempt
Agio Pharmaceuticals Ltd.India
Ambica International Corporation
DRP-2798
Jul 13, 2031
CholtrolAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 100's)
RxVAT-exempt
Agio Pharmaceuticals Ltd.India
Ambica International Corporation
DRP-4371
Apr 11, 2028
CorestalAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 7's Box of 28's; Alu/Alu Blister Pack x 10's Box of 30's and 100's
RxVAT-exempt
Dr. Reddy's Laboratories Ltd. (Formulation Unit 3)India
SMHP PHARMACEUTICALS INCORPORATED
DRP-5074
May 24, 2027
CorestalAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu blister pack x 7's (Box of 28's); Alu/Alu blister pack x 10's (Box of 30's and100's)
RxVAT-exempt
Dr. Reddy's Laboratories Ltd. (Formulation Unit 3)India
SMHP Pharmaceuticals Incorporated
DRP-5075
May 24, 2027
CorestalAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu-Alu Blister Pack x 7's (Box of 28's); Alu-Alu Blister Pack x 10's (Box of 30's and100's)
RxVAT-exempt
Dr. Reddy's Laboratories Ltd. (Formulation Unit 3)India
SMHP Pharmaceuticals Incorporated
DRP-5047
May 24, 2027
CrystorvasAtorvastatin (as calcium trihydrate)
20mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Duopharma Manufacturing (Bangi) Sdn. Bhd.Malaysia
DB (Philippines), Inc.
DR-XY48765
Jun 6, 2028
CrystorvasAtorvastatin (as calcium trihydrate)
40mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Duopharma Manufacturing (Bangi) Sdn. Bhd.Malaysia
DB (Philippines), Inc.
DR-XY48766
Jun 6, 2028
DescolAtorvastatin (as calcium trihydrate)
10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's Box of 10's
RxVAT-exempt
Nabiqasim Industries (Private) LimitedPakistan
Accesspoint International Trading Inc.
DR-XY44886
Oct 28, 2028
DescolAtorvastatin (as calcium trihydrate)
20 mg Film-Coated TabletAlu/PVC Blister pack x 10's Box of 10's
RxVAT-exempt
Nabiqasim Industries (Private) LimitedPakistan
Accesspoint International Trading Inc.
DR-XY44885
Oct 28, 2028
Duvaztor-20Atorvastatin
20 mg Film-Coated TabletAlu-Alu Blister Pack x 10’s (Box of 50’s and 100’s)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
HLM Pharmaceutical Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-1720-03
Aug 25, 2029
Duvaztor-40Atorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10‘s (Box of 50’s and 100’s)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
HLM Pharmaceutical Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-2254-03
Mar 12, 2031
DystatinAtorvastatin (as Calcium)
10 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
—
DRP-5589
Jun 27, 2028
DystatinAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Actimed, Inc.
DRP-6540
Jul 8, 2029
DystatinAtorvastatin (as calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
—
DRP-6818
Feb 9, 2030
Eldi-ElAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/ PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Medisure Laboratories Pakistan (Pvt.) Ltd.Pakistan
Euro-Care Products PhilippinesImporter: Accesspoint International Trading Inc.
DRP-6126-02
Apr 5, 2037
EmdistatAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu / ALu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Zest PharmaIndia
MD9 Pharma and Distribution Inc.Importer: Sahar International Trading Inc.Trader: NGB Laboratories Pvt. Ltd.,
DRP-16531-01
Mar 16, 2030
EndvastorAtorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 30's
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-3123-04
Jul 12, 2029
Eostatin 80Atorvastatin (as calcium)
80 mg Film-Coated TabletAlu-Alu Blister Pack 1 x 10's (Box of 30's)
RxVAT-exempt
Umedica Laboratories Pvt. LtdIndia
Eon Pharmatek, Inc.
DRP-16247
Jan 9, 2030
Farmavast 20Atorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s)
RxVAT-exempt
Agio Pharmaceuticals LimitedIndia
Diafarm Inc.Importer: Ambica International Corporation
DRP-2796-02
Sep 4, 2037
FaticonAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Healer’s Lab (Unit II)India
Neos-King Pharma Inc.Importer: Pharmakon Biotec Inc.
DRP-13973-03
May 26, 2028
FedstatinAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Federal Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-10747-02
Aug 6, 2037
FedstatinAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Federal Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-10748-04
Aug 17, 2037
FlorvastAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 30's
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Bansan Pharma DistributorImporter: Ambica International Corporation
DRP-3109-05
Jul 12, 2029
Florvast 80Atorvastatin (as Calcium Trihydrate)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Bansan Pharma DistributorImporter: Ambica International Corporation
DRP-4295-03
Mar 13, 2028
FredtorAtorvastatin (As Calcium)
10mg Film Coated TabletsAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
AMB HK Enterprises Inc.
DRP-11881
May 18, 2027
FredtorAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
AMB HK Enterprises, Inc.
DRP-11880
May 18, 2032
FredtorAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals Ltd.India
AMB HK Enterprises Inc.
DRP-11879
May 18, 2032
FredtorAtorvastatin (As Calcium)
80mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
AMB HK Enterprises Inc.
DRP-11878
May 18, 2027
FtorAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
AMB HK Enterprises Inc.
DRP-15841
Sep 20, 2029
FtorAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
AMB HK Enterprises Inc.
DRP-15842
Sep 20, 2029
FtorAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
AMB HK Enterprises Inc.
DRP-15843
Sep 20, 2029
FtorAtorvastatin (as calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
AMB HK Enterprises Inc.
DRP-15844
Sep 20, 2029
FulvastAtorvastatin (as Calcium)
40 mg Film-Coated TabletAluminum Strip Foil x 10's (Box of 100's)
RxVAT-exempt
Diamond Laboratories Inc.Philippines
Full Health International Pharma
DRP-7606
Jun 17, 2029
FulvastAtorvastatin (as Calcium)
80 mg Film-Coated TabletAluminum Strip Foil x 10's (Box of 100's)
RxVAT-exempt
Diamond Laboratories, Inc.Philippines
Full Health International Pharma
DRP-7605
May 23, 2029
Genvazt-20Atorvastatin (as Calcium Trihydrate)
20mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
ACME Formulations Pvt. Ltd.India
GA2 Pharmaceutical Inc.Importer: Medinova Pharmaceutical, Inc.
DRP-12155-01
Jun 22, 2027
Gitor-40Atorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Gijun Trading Inc.Importer: Ambica International Corporation
DRP-3109-10
Jul 12, 2029
Globastat-20Atorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30's and 100's)
RxVAT-exempt
Akriti Pharmaceuticals Pvt. Ltd.India
Qualifirst Health, Inc.Importer: Aglobal Care, Inc.Trader: PPJ Pharma Pvt. Ltd.
DRP-8059
Mar 27, 2027
Gostat 10Atorvastatin
10 mg Film-Coated TabletAlu-Alu Blister Pack x 10’s Box of 100’s
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Applied Pharmaceuticals Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-1721-03
Aug 25, 2029
Gostat 20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Applied Pharmaceutical Distribution Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-9837-01
Jun 23, 2031
Gostat-40Atorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10‘s (Box of 100’s)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Applied Pharmaceutical Distribution Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-2254-04
Mar 12, 2031
Gostin-10Atorvastatin (as Calcium Trihydrate)
10 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 30's. Box of 100's)
RxVAT-exempt
ACME Formulations Pvt. Ltd.India
Applied Pharmaceutical Distribution Inc.Importer: Medinova Pharmaceutical Inc.
DRP-12225-02
Jul 12, 2027
Gostin-10Atorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's and 30's)
RxVAT-exempt
Ratnaris Pharmaceuticals Private LimitedIndia
Applied Pharmaceutical Distribution Inc.Importer: Medinova Pharmaceutical Inc.
DRP-15715-02
Sep 5, 2029
Gostin-20Atorvastatin (as Calcium Trihydrate)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, Box of 100's)
RxVAT-exempt
Acme Formulations Pvt. Ltd.India
Applied Pharmaceutical DistributionImporter: Medinova Pharmaceutical Inc.
DRP-12155-03
Jun 22, 2027
Gostin-20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's; Box of 100's)
RxVAT-exempt
Ratnatris Pharmaceuticals Private LimitedIndia
Applied Pharmaceutical Distribution Inc.Importer: Medinova Pharmaceutical Inc.
DRP-15714-01
Sep 6, 2029
Gotorvast 10Atorvastatin (As Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
Applied Pharmaceutical Distribution Inc.Importer: AMB HK Enterprises Inc.
DRP-14015-01
Jun 6, 2028
Gotorvast 20Atorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
Applied Pharmaceutical Distribution Inc.Importer: AMB HK Enterprises Inc.
DRP-14014-01
Jun 6, 2028
Gotorvast 40Atorvastatin (As Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
Applied Pharmaceutical Distribution Inc.Importer: AMB HK Enterprises Inc.
DRP-14013-01
Jun 6, 2028
Gotorvast 80Atorvastatin (as Calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s and 100’s)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
Applied Pharmaceutical Distribution Inc.Importer: AMB HK Enterprises Inc.
DRP-14012-02
Jun 6, 2028
GovastinAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Applied Pharmaceutical Distribution Inc.Importer: Ambica International Corporation
DRP-3109-08
Jul 12, 2029
GovastinAtorvastatin (as calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Applied Pharmaceutical Distribution IncImporter: Ambica International Corporation
DRP-10749-07
Nov 15, 2031
H-Ator 20Atorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 50’s and 100's)
RxVAT-exempt
Bioveeta Laboratories Pvt. Ltd.India
Intermac Pharmaceutical Inc.
DRP-5815
Sep 3, 2029
ItorvazAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
The ACME Laboratories Ltd.Bangladesh
Bell-Kenz Pharma Inc.Importer: Euro Generics International Phils., Inc.
DRP-3654
Aug 3, 2031
ItorvazAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack of 10's (Box of 30's)
RxVAT-exempt
The ACME Laboratories LimitedBangladesh
Bell-Kenz Pharma Inc.Importer: Euro Generics International Phils., Inc.
DRP-6081
May 18, 2027
ItorvazAtorvastatin (as Calcium)
80 mg Film-coated TabletAlu/Alu Blister Pack of 10's (Box of 30's)
RxVAT-exempt
The ACME Laboratories LimitedBangladesh
Bell-Kenz Pharma Inc.Importer: Euro Generics International Phils., Inc.
DRP-6080
May 18, 2027
Khrizstatin 40Atorvastatin (as calcium)
40 mg Film-Coated TabletAlu-Alu blister x 10's (Box of 100's)
RxVAT-exempt
Ceclogen Generics Private Ltd.India
Importer: Khriz Pharma Trading Inc.
DRP-13270
Feb 8, 2028
Klotor-SAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Starpharm, Inc.Importer: Ambica International Corporation
DRP-3109-09
Jul 12, 2029
KoditorzAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Kodi Biosciences IncImporter: Ambica International CorporationTrader: Endurance Healthcare Pvt. Ltd.
DRP-5137-06
Feb 13, 2029
KorvastAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Opaque White PVC blister pack x 40's Box of 40's
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Konzept Convenience and Drug Store Corp.
DRP-5880-04
Sep 9, 2029
KorvastAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
KONZEPT CONVENIENCE AND DRUG STORE CORP.
DRP-6340-04
Sep 25, 2031
KorvastAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Konzept Convenience And Drug Store Corp.
DRP-6339-04
Sep 19, 2031
KorvastAtorvastatin (as Calcium)
80 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Konzept Convenience And Drug Store Corp.
DRP-6341-04
Sep 19, 2031
Lemchole 20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambitech Biopharmaceuticals Inc.Importer: Ambica International Corporation
DRP-10747-09
Aug 6, 2037
Lemtor 10Atorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Rilem Pharma Corp.Importer: Ambica International Corporation
DRP-10746-04
Sep 22, 2031
Lemtor 20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Rilem Pharma Corp.Importer: Ambica International Corporation
DRP-10747-10
Oct 17, 2031
Lemtor 40Atorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Rilem Pharma Corp.Importer: Ambica International Corporation
DRP-10748-08
Sep 23, 2031
Lemtor 80Atorvastatin (as calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Rilem Pharma Corp.Importer: Ambica International Corporation
DRP-10749-04
Sep 4, 2031
LestorAtorvastatin (As Calcium)
10mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
AMB HK Enterprises Inc.
DRP-14015
Jun 6, 2028
LestorAtorvastatin (As Calcium)
20mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
AMB HK Enterprises Inc.
DRP-14014
Jun 6, 2028
LestorAtorvastatin (As Calcium)
40mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
AMB HK Enterprises Inc.
DRP-14013
Jun 6, 2028
LestorAtorvastatin (As Calcium)
80mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
AMB HK Enterprises Inc.
DRP-14012
Jun 6, 2028
LieutenantAtorvastatin (as calcium)
40 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-6922-01
Oct 10, 2031
Lifetor 10Atorvastatin (as Calcium Trihydrate)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's; Box of 100's)
RxVAT-exempt
ACME Formulations Pvt. Ltd.India
Life And Health Source Pharmaceutical Distribution Co.Importer: Medinova Pharmaceutical Inc.
DRP-12225-04
Jul 12, 2027
Lifetor 20Atorvastatin (as Calcium Trihydrate)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's; Box of 100's)
RxVAT-exempt
ACME Formulations Pvt. Ltd.India
Life and Health Source Pharmaceutical Distribution Co.Importer: Medinova Pharmaceutical, Inc.
DRP-12155-04
Jun 22, 2027
LifortAtorvastatin (as Calcium)
10 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 30's)
RxVAT-exempt
Bal Pharma LimitedIndia
Pharmakon Biotec Inc.
DRP-5127
Feb 12, 2029
LifortAtorvastatin (as Calcium)
20 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 30's)
RxVAT-exempt
Bal Pharma LimitedIndia
Pharmakon Biotec Inc.
DRP-5128
Feb 12, 2029
Linmervast-20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International CorporationTrader: Endurance Healthcare Pvt. Ltd.
DRP-4879-05
Nov 7, 2028
Linmervast-40Atorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Linmer Pharma IncorporatedImporter: Ambica International CorporationTrader: Endurance Healthcare Ltd.
DRP-5137-02
Feb 13, 2029
Lipend 10Atorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 30's
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambica International CorporationTrader: Endurance Healthcare Ltd.
DRP-5339
Jun 18, 2029
Lipend 20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Macropharma CorporationImporter: Ambica International CorporationTrader: Endurance Healthcare Pvt. Ltd.
DRP-4879
Nov 7, 2028
LipiblacAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
RSG Pharma TradingImporter: Ambica International CorporationTrader: Endurance Healthcare Ltd.
DRP-4879-03
Nov 7, 2028
Lipimize-A 15Atorvastatin (as besilate) + Atorvastatin (as calcium)
5 mg/10 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-6802
Aug 19, 2030
LipinilAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 50's)
RxVAT-exempt
Bioveeta Laboratories Pvt. LtdIndia
Jaera Pharma And Medical Supplies TradingImporter: Intermac Pharmaceutical Inc.
DRP-5815-02
Sep 3, 2029
Lipinov 10Atorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Ratnatris Pharmaceuticals Private LimitedIndia
GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc.
DRP-15715-03
Sep 5, 2029
Lipinov 20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Ratnatris Pharmaceuticals Private LimitedIndia
GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc.
DRP-15714-03
Sep 6, 2029
LipitorAtorvastatin (as calcium)
10 mg TabletAlu-PA/Alu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Pfizer Pharmaceuticals LLCPuerto Rico
Importer: PF OFG Philippines Inc.
DRP-3361
Jun 29, 2027
LipitorAtorvastatin (as calcium)
20 mg TabletAlu-PA/Alu/PVC Blister Pack (Box of 10 blister packs x 10's)
RxVAT-exempt
Pfizer Pharmaceuticals LLCPuerto Rico
Importer: PF OFG Philippines Inc.
DRP-3362
Jul 21, 2027
LipitorAtorvastatin (as calcium)
40 mg TabletAlu-PA/Alu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Pfizer Pharmaceuticals LLCPuerto Rico
Importer: PF OFG Philippines Inc.
DRP-3363
Jun 29, 2027
LipitorAtorvastatin (as calcium)
80 mg TabletAlu-PA/Alu/PVC Blister Pack x 10's (Box of 10's); Alu-PA/Alu/PVC Blister Pack x 1's (Box of 1's) as Physician's Sample
RxVAT-exempt
Pfizer Pharmaceuticals LLCPuerto Rico
Importer: PF OFG Philippines Inc.
DRP-3364
Jul 21, 2027
LipitrolAtorvastatin
10 mg TabletWhite opaque PVC/Alu foil blister pack x 10's (Box of 100's)
RxVAT-exempt
Scheele Laboratories Phils., IncPhilippines
—
DRP-7531
Dec 1, 2027
LipitrolAtorvastatin
20 mg TabletClear PVC/Alu foil blister pack x 10's (Box of 100's)
RxVAT-exempt
Scheele Laboratories Phils., Inc.Philippines
—
DRP-7530
Dec 1, 2027
LipitrolAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Scheele Laboratories Phil. Inc.Philippines
—
DRP-8593
Dec 20, 2029
Lipizen-20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Kodapharm Med Corp.Importer: Ambica International Corporation
DRP-10747-05
Sep 19, 2037
Lipizen-40Atorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Kodapharm Med Corp.Importer: Ambica International Corporation
DRP-10748-06
Aug 12, 2037
Lipotrim-40Atorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 100's)
RxVAT-exempt
Maple Pharmaceuticals (Pvt.) Ltd.Pakistan
Ambica International Corporation
DRP-4697
Sep 13, 2028
LolipAtorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 50's)
RxVAT-exempt
Kusum Healthcare Private LimitedIndia
Kusum Healthcare Private Limited Branch Office
DR-XY42472
Mar 4, 2031
LolipAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30's and 50's)
RxVAT-exempt
Kusum Healthcare Pvt. Ltd.India
Kusum Healthcare Private Limited Branch Office
DRP-10505
Mar 6, 2031
Madrovas-20Atorvastatin (as calcium trihydrate)
20 mg Film-Coated TabletAlu/Alu blister pack x 10 tablets (Box of 30 tablets)
RxVAT-exempt
The Madras PharamceuticalsIndia
Aglobal Care, Inc.
DRP-13501
Mar 2, 2028
Mayor 10Atorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation
DRP-10746-02
Aug 17, 2037
Mayor 20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation
DRP-10747-07
Aug 17, 2037
Mayor 80Atorvastatin (as calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation
DRP-10749-02
Aug 12, 2037
Mayor-40Atorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation
DRP-10748-01
Aug 6, 2037
Medivazt-20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Ratnatris Pharmaceuticals Private LimitedIndia
Medinova Pharmaceutical Inc.
DRP-15714
Sep 6, 2029
MEVAGARDAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 8's Box of 40's
RxVAT-exempt
J.M. TOLMANN LABORATORIES INC.Philippines
WESTFIELD PHARMACEUTICALS, INC.
DRP-3175-02
Jan 4, 2030
NeostatAtorvastatin (as calcium)
10 mg TabletWhite Opaque PVC/Alu Foil Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Scheele Laboratories Phils., Inc.Philippines
PHARMA HUB CORPORATION
DRP-7531--01
Dec 1, 2027
NeostatAtorvastatin (as calcium)
20 mg TabletClear PVC/Alu Foil Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Scheele Laboratories Phils., Inc.Philippines
Pharma Hub Corporation
DRP-7530-01
Dec 1, 2027
NeostatinAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Diafarm Inc.Importer: Ambica International Corporation
DRP-10746-03
Aug 6, 2037
NeostatinAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Diafarm Inc.Importer: Ambica International Corporation
DRP-10747-08
Aug 17, 2037
NeostatinAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Diafarm Inc.Importer: Ambica International Corporation
DRP-10748-07
Aug 6, 2037
NeostatinAtorvastatin (as calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Diafarm Inc.Importer: Ambica International Corporation
DRP-10749-01
Aug 19, 2037
NoneAtorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30s)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Dyna Drug Corporation
DR-XY38612
Oct 11, 2030
NoneAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Ultramed Pharma, Inc.
DR-XY44229
Feb 27, 2030
NoneAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Diafarm Inc.Importer: Ambica International Corporation
DRP-10746-05
Nov 15, 2031
NoneAtorvastatin (as Calcium Trihydrate)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Acme Formulations Pvt. Ltd.India
Qualifirst Health Inc.Importer: Medinova Pharmaceutical, Inc.
DRP-12225-05
Jul 12, 2027
NoneAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu / Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Medisky PharmaceuticalsIndia
SwissPharmatech Co.Importer: Aglobal Care, Inc.
DRP-15640-01
Aug 14, 2029
NoneAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s)
RxVAT-exempt
Agio Pharmaceuticals LimitedIndia
International Pharmaceuticals, Inc.Importer: Ambica International Corporation
DRP-2796-01
Sep 22, 2037
NoneAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100’s)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Rose Pharmacy, Incorporated
DRP-5589-03
Jun 27, 2028
NoneAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
St. Joseph DrugstoreTrader: Innogen Pharmaceuticals, Inc.
DRP-5614-05
Mar 19, 2029
NoneAtorvastatin (as calcium)
10 mg TabletAlu-PA/Alu/PVC Blister Pack 10's Box of 100's
RxVAT-exempt
Pfizer Pharmaceuticals LLCPuerto Rico
PHILUSA CORPORATIONImporter: PF OFG Philippines, Inc.
DRP-3361-02
Jun 29, 2027
NoneAtorvastatin
10 mg TabletAlu-PA / Alu/ PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Viatris Pharmaceuticals LLCUSA
Viatris Pharmaceuticals, Inc.Importer: Viatris, Inc.
DRP-3361-03
Jun 29, 2027
NoneAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Dyna Drug Corporation
DR-XY39434
May 10, 2031
NoneAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Alkem Laboratories CorporationImporter: Ambica International Corporation
DRP-10747-01
Sep 11, 2037
NoneAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
PharmaVital Corp.Importer: Ambica International Corporation
DRP-10747-11
Nov 15, 2031
NoneAtorvastatin (as Calcium Trihydrate)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Acme Formulation Pvt. Ltd.India
Qualifirst Health Inc.Importer: Medinova Pharmaceutical Inc.
DRP-12155-05
Jun 22, 2027
NoneAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu-Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Flamingo Pharmaceuticals Ltd.India
Hexagon Pharmaceuticals
DRP-2383
May 21, 2029
NoneAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu-Alu Blister Pack x 10’s (Box of 30’s and Box of 50’s)
RxVAT-exempt
XL Laboratories Pvt. Ltd.India
Pharex Healthcare CorporationImporter: Ambica International Trading Corp.
DRP-2922
Apr 14, 2031
NoneAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International CorporationTrader: Endurance Healthcare Pvt. Ltd.
DRP-4879-01
Nov 7, 2028
NoneAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Corbridge Group Phils., Inc.Importer: Ambica International CorporationTrader: Endurance Healthcare Ltd.
DRP-4879-02
Nov 7, 2028
NoneAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
International Pharmaceuticals, Inc.Importer: Ambica International CorporationTrader: Endurance Healthcare Ltd.
DRP-4879-06
Nov 7, 2028
NoneAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Rose Pharmacy, Incorporated
DRP-5155-04
Sep 2, 2028
NoneAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Medisure Laboratories Pakistan (Pvt.) LimitedPakistan
Reta DrugImporter: Accesspoint International Trading Inc.
DRP-6126-03
Mar 21, 2037
NoneAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu-PVC Blister White Opaque x 10’s (Box of 100’s)
RxVAT-exempt
Sydenham Laboratories, Inc.Philippines
Actimed, Inc.
DRP-6128-04
May 5, 2031
NoneAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
St. Joseph DrugstoreTrader: Innogen Pharmaceuticals, Inc.
DRP-7120-01
Mar 19, 2029
NoneAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30's and 100's)
RxVAT-exempt
Akriti Pharmaceuticals Pvt. LtdIndia
TGP Pharma Inc.Importer: Aglobal Care, IncTrader: PPJ Pharma Pvt. Ltd
DRP-8059-02
Mar 27, 2027
NoneAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100's)
RxVAT-exempt
Akriti Pharmaceuticals Pvt. LtdIndia
SwissPharmatech Co.Importer: Aglobal Care, Inc.Trader: PPJ Pharma Pvt. Ltd
DRP-8059-04
Mar 27, 2027
NoneAtorvastatin (as calcium)
20 mg TabletAlu-PA/Alu/PVC Blister Pack (Box of 100's)
RxVAT-exempt
Pfizer Pharmaceutical LLCPuerto Rico
PHILUSA CORPORATIONImporter: PF OFG Philippines, Inc.
DRP-3362-02
Jul 21, 2027
NoneAtorvastatin
20 mg TabletAlu-PA/Alu/PVC Blister Pack (Box of 10 blister packs x 10's); (Box of 1 blister pack x 1's as Physician's Sample)
RxVAT-exempt
Viatris Pharmaceuticals LLCUSA
Viatris Pharmaceuticals, Inc.Importer: Viatris, Inc.
DRP-3362-03
Jul 21, 2027
NoneAtorvastatin (as Calcium)
20mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Micro Labs LimitedIndia
ADP Pharma CorporationImporter: Brown & Burk Philippines, Inc.
DRP-7056-01
Oct 2, 2027
NoneAtorvastatin (as calcium)
40 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Micro Labs LimitedIndia
ADP Pharma CorporationImporter: Brown & Burk Philippines Inc.
DRP-9583-01
Oct 23, 2028
NoneAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Alkem Laboratories CorporationImporter: Ambica International Corporation
DRP-10748-02
Aug 17, 2037
NONEAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
PharmaVital Corp.Importer: Ambica International Corporation
DRP-10748-09
Nov 15, 2031
NoneAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
Dyna Drug CorporationImporter: AMB HK Enterprises Inc.
DRP-11879-01
May 18, 2027
NoneAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Ranbaxy (Malaysia) SDN. BHDMalaysia
Ritemed Phils., Inc.
DRP-1232
Feb 2, 2029
NoneAtorvastatin (As Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30’s and 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
Qualifirst Health Inc.Importer: AMB HK Enterprises Inc.
DRP-14013-04
Jun 6, 2028
NoneAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lek Pharmaceuticals D.D.Slovenia
Watsons Personal Care Stores (Philippines), Inc.Importer: Sandoz Philippines Corporation
DRP-2279-01
Aug 13, 2029
NoneATORVASTATIN (AS CALCIUM)
40 MG FILM-COATED TABLETALU/ALU BLISTER PACK X 8'S BOX OF 40'S
RxVAT-exempt
J.M. TOLMANN LABORATORIES INC.Philippines
TGP Pharma, Inc.
DRP-3175
Jan 4, 2030
NoneAtorvastatin (as Calcium)
40 MG FILM-COATED TABLETALU/ALU BLISTER PACK X 8 'S BOX OF 40'S
RxVAT-exempt
J.M. TOLMANN LABORATORIES INC.Philippines
FIRSTMED THERACONCEPT INC.
DRP-3175-07
Jan 4, 2030
NoneAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
XL Laboratories Pvt. Ltd.India
United Laboratories, Inc.Importer: Ambica International Corporation
DRP-3224
Sep 2, 2029
NoneAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
XL Laboratories Pvt. Ltd.India
Actimed, Inc.Importer: Ambica International Corporation
DRP-3224-01
Sep 2, 2029
NoneAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's)
RxVAT-exempt
Agio Pharmaceuticals Ltd.India
South Star DrugImporter: Ambica International Corporation
DRP-4371-01
Apr 11, 2028
NoneAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International CorporationTrader: Endurance Healthcare Ltd.
DRP-5137-01
Feb 13, 2029
NoneAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International CorporationTrader: Endurance Healthcare Ltd.
DRP-5137-03
Feb 13, 2029
NoneAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
International Pharmaceuticals, Inc.Importer: Ambica International Corporation
DRP-5137-04
Feb 13, 2029
NoneAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s and Box of 100’s)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Actimed, Inc.Importer: Ambica International CorporationTrader: Endurance Healthcare Pvt. Ltd.
DRP-5137-07
Feb 13, 2029
NoneAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu-PVC Blister White Opaque x 10’s (Box of 100’s)
RxVAT-exempt
Sydenham Laboratories, Inc.Philippines
Actimed, Inc.
DRP-6125-01
May 5, 2031
NoneAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Rose Pharmacy, Incorporated
DRP-6540-03
Jul 8, 2029
NoneAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 24's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
St. Joseph DrugstoreTrader: Dr. Zen’s Research, Inc.
DRP-7551-02
May 12, 2030
NoneAtorvastatin (as calcium)
40 mg TabletAlu-PA/Alu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Pfizer Pharmaceuticals LLCPuerto Rico
Philusa CorporationImporter: PF OFG Philippines, Inc.
DRP-3363-02
Jun 29, 2027
NoneAtorvastatin
40 mg TabletAlu-PA/Alu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Viatris Pharmaceuticals LLCUSA
Viatris Pharmaceuticals, Inc.Importer: Viatris, Inc.
DRP-3363-03
Jun 29, 2027
NoneAtorvastatin (as calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 24's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
TGP Pharma Inc.Trader: Euro-Health Care Exponents, Inc.
DR-XY37435
Feb 4, 2030
NoneAtorvastatin (as calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Reta DrugImporter: Ambica International Corporation
DRP-10749-03
Aug 17, 2037
NoneAtorvastatin (As Calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30’s and 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
Qualifirst Health Inc.Importer: AMB HK Enterprises Inc.
DRP-14012-03
Jun 6, 2028
NoneAtorvastatin (as calcium trihydrate)
80 mg Film-Coated TabletAlu/Alu Blister pack x 10's (Box of 100’s)
RxVAT-exempt
Healer's Lab (Unit II)India
Reta DrugImporter: Pharmakon Biotec Inc.
DRP-15406-02
Jul 3, 2029
NoneAtorvastatin (as Calcium Trihydrate)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Alkem Laboratories CorporationImporter: Ambica International Corporation
DRP-4295-04
Mar 13, 2028
NoneAtorvastatin (as calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
TGP Pharma Inc.
DRP-6818-01
Feb 9, 2030
NoneAtorvastatin (as calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Rose Pharmacy, Incorporated
DRP-6818-02
Feb 9, 2030
NoneAtorvastatin (as calcium)
80 mg TabletAlu-PA/Alu/PVC Blister Pack x 10's Box of 100's
RxVAT-exempt
Pfizer Pharmaceuticals LLCPuerto Rico
PHILUSA CORPORATIONImporter: PF OFG Philippines, Inc.
DRP-3364-02
Jul 21, 2027
NoneAtorvastatin
80 mg TabletAlu-PA /Alu/ PVC Blister Pack x 10's (Box of 100's); Alu-PA/Alu/PVC Blister Pack x 1's (Box of 1's) as Physician's Sample
RxVAT-exempt
Viatris Pharmaceuticals LLCUSA
Viatris Pharmaceuticals, Inc.Importer: Viatris, Inc.
DRP-3364-03
Jul 21, 2027
Novaztor 20Atorvastatin Calcium
20mg Film-Coated TabletAlu-Alu Blister Pack by 10’s (Box of 30's and 100’s)
RxVAT-exempt
Salud Care (India) LimitedIndia
Medinova Pharmaceutical Inc.
DRP-19157
Nov 11, 2031
Novaztor-40Atorvastatin Calcium
40mg Film-Coated TabletAlu-Alu Blister x 10’s (Box of 30’s and 100’s)
RxVAT-exempt
Salud Care (India) LimitedIndia
Medinova Pharmaceutical Inc.
DRP-19156
Nov 11, 2031
NutorAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 50's and 100's)
RxVAT-exempt
Bioveeta Laboratories Pvt. Ltd.India
Kodapharm Med Corp.Importer: Intermac Pharmaceutical Inc.
DRP-5815-01
Sep 3, 2029
OnestatinAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
—
DR-XY42164
Jun 27, 2028
OnestatinAtorvastatin (as calcium)
20 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
One Pharma Marketing Inc.
DRP-4633
Dec 26, 2027
OP-AtorAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
Orient Pearl Med Pharma, Inc.Importer: AMB HK Enterprises Inc.
DRP-11880-01
May 18, 2027
OP-ATORAtorvastatin (as Calcium Trihydrate)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Healer's Lab (Unit II)India
Orient Pearl Med Pharma Inc.Importer: Pharmakon Biotec Inc.
DRP-15961-05
Oct 4, 2029
OrvastAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 40's)
RxVAT-exempt
J.M. TOLMANN LABORATORIES INC.Philippines
Medirich Pharma Distribution Corp.
DRP-3175-01
Jan 4, 2030
ProtemaxAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Ranbaxy (M) Sdn. Bhd.Malaysia
UNILAB, INC.
DRP-1233-01
Feb 2, 2029
ProtemaxAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Ranbaxy (Malaysia) Sdn. Bhd.Malaysia
Unilab Inc.
DRP-1234-01
Feb 2, 2029
ProtemaxAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 100's
RxVAT-exempt
Ranbaxy (Malaysia) SDN. BHDMalaysia
UNILAB, INC.
DRP-1232-01
Aug 12, 2037
ProvasAtorvastatin (as calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 24's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Dr. Zen’s Research, Inc.
DR-XY37441
Feb 9, 2030
Q-TorAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 30's
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Quad-Gen PharmaceuticalsImporter: Ambica International Corporation
DRP-3109-07
Jul 12, 2029
RanvastAtorvastatin(As Calcium)
20 mg Film-Coated TabletBlister Pack x 10's (Box of 100's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
Philgen Pharmaceuticals, Inc.
DRP-2778
Jul 14, 2027
RanvastAtorvastatin (as calcium)
40 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mercury Laboratories Ltd.India
Philgen Pharmaceuticals, Inc.
DRP-16465
Mar 20, 2030
RanvastAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Centaurion Laboratories Pvt. Ltd.india
Philgen Pharmaceuticals Inc.
DRP-5224
Jun 28, 2027
RedulipAtorvastatin
10 mg Film-Coated TabletAlu-Alu Blister Pack x 10’s (Box of 50’s and 100’s)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Suhitas Pharmaceuticals Inc.
DRP-1721
Aug 25, 2029
Regi2RAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 20's (Box of 100's); Alu/Opaque White PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Regimed Pharmaceutical Distributor
DRP-5880-08
Sep 9, 2029
REGI2RAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 20's (Box of 100's and 200's); Alu/Opaque White PVC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Regimed Pharmaceutical Distributor
DRP-6340-07
Sep 11, 2030
REGI2RAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's and 200's); Alu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories, Inc.Philippines
Regimed Pharmaceutical Distributor
DRP-6339-08
Sep 11, 2030
Regi2RAtorvastatin (as Calcium)
80 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's); Alu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Regimed Pharmaceutical Distributor
DRP-6341-07
Sep 11, 2030
RestatAtorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Medisure Laboratories Pakistan (Pvt.) LimitedPakistan
Rexmed Pharmaceutical SalesImporter: Accesspoint International Trading Inc.
DRP-6127-01
May 20, 2031
RestatAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Medisure Laboratories Pakistan (Pvt.) LimitedPakistan
Rexmed Pharmaceutical SalesImporter: Accesspoint International Trading Inc.
DRP-6126-01
Apr 16, 2037
RetastatAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Reta DrugImporter: Suhitas Pharmaceuticals, Inc.
DRP-9838-01
Jun 23, 2031
RetastatAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Umedica Laboratories Pvt.Ltd.India
Reta DrugImporter: SUHITAS PHARMACEUTICALS INC.
DRP-9837-03
Jun 23, 2031
RetastatAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10‘s (Box of 100’s)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Reta DrugImporter: Suhitas Pharmaceuticals Inc.
DRP-2254-06
Mar 16, 2031
RetavastatinAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Reta DrugImporter: Ambica International Corporation
DRP-10748-03
Aug 12, 2037
Saatin 10Atorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
GX International, Inc.
DRP-5589-01
Jun 27, 2028
Saatin 20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
GX International, Inc.
DRP-5155-01
Sep 2, 2028
Saatin 40Atorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
HIZON LABORATORIES, INC.Philippines
GX INTERNATIONAL, INC.
DRP-6540-01
Jul 8, 2029
SavtatinAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's & 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-10746-01
Sep 11, 2037
SavtatinAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-10747-04
Aug 17, 2037
SavtatinAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-10748-05
Aug 19, 2037
SavtatinAtorvastatin (as calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-10749-05
Sep 22, 2031
SITIvast-40Atorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Zest PharmaIndia
Sahar International Trading, Inc.
DR-XY44319
Mar 16, 2030
SITIvast-40Atorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu blister Pack x 10's (Box of 100's)
RxVAT-exempt
Zest PharmaIndia
Sahar International Trading, Inc.Trader: NGB Laboratories Pvt. Ltd.,
DRP-16531
Mar 16, 2030
StadinAtorvastatin (as calcium trihydrate)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lek S.A.Poland
Stada Philippines, Inc.Importer: Sandoz Philippines Corporation
DRP-15501-01
Jul 29, 2029
StadinAtorvastatin (as calcium trihydrate)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lek S.A.Poland
Stada Philippines, Inc.Importer: Sandoz Philippines Corporation
DRP-15500-01
Jul 29, 2029
StadinAtorvastatin (as calcium trihydrate)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lek S.A.Poland
Stada Philippines, Inc.Importer: Sandoz Philippines Corporation
DRP-15499-01
Jul 29, 2029
Stalip-10Atorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Diafarm Inc.Importer: Ambica International Corporation
DRP-3123
Jul 12, 2029
Stalip-40Atorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 30's and 100's
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Diafarm Inc.Importer: Ambica International Corporation
DRP-3109
Jul 12, 2029
Stalip-80Atorvastatin (as Calcium Trihydrate)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 100's
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Diafarm Inc.Importer: Ambica International Corporation
DRP-4295
Mar 13, 2028
Sunvas 10Atorvastatin (as calcium trihydrate)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Sun Pharmaceutical Industries LimitedIndia
Sun Pharma Philippines, Inc.
DRP-15526
Jul 31, 2029
Sunvas 20Atorvastatin (as calcium trihydrate)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Sun Pharmaceutical Industries LimitedIndia
Sun Pharma Philippines, Inc.
DRP-15525
Jul 31, 2029
Sunvas 40Atorvastatin (as calcium trihydrate)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Sun Pharmaceutical Industries LimitedIndia
Sun Pharmaceutical Industries Limited
DRP-15524
Jul 31, 2029
Sunvas 80Atorvastatin (as calcium trihydrate)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Sun Pharmaceutical Industries LimitedIndia
Sun Pharma Philippines, Inc.
DRP-15523
Jul 31, 2029
SydenvastAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu-PVC Blister White Opaque x 10's (Box of 100's)
RxVAT-exempt
Sydenham Laboratories, Inc.Philippines
—
DRP-6128
May 5, 2031
SydenvastAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu-PVC Blister White Opaque x 10's (Box of 100's)
RxVAT-exempt
Sydenham Laboratories, Inc.Philippines
—
DRP-6125
May 5, 2031
TechnostatAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
One Technodrug Life Sciences Inc.Importer: Ambica International Corporation
DRP-3109-01
Jul 12, 2029
Technostat-10Atorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
One Technodrug Life Sciences Inc.Importer: Ambica International CorporationTrader: Endurance Healthcare Ltd.
DRP-5339-02
Jun 18, 2029
TenienteAtorvastatin (as calcium)
40 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation
DRP-6922-02
Oct 16, 2031
TG-TorAtorvastatin
20 mg Film-Coated TabletsClear PVC / Alu foil blister pack x 10's (Box of 100's)
RxVAT-exempt
Scheele Laboratories Phils., Inc.Philippines
TGIF Pharmaceutical Trading Inc.
DRP-7530-04
Dec 1, 2027
Thor-40Atorvastatin (as calcium trihydrate)
40 mg Film-Coated TabletAlu/ Alu Blister Pack x 10's (Box of 100’s)
RxVAT-exempt
Healer's Lab (Unit II)India
RL Pharma Enterprises Inc.Importer: Pharmakon Biotec Inc.
DRP-15961-02
Oct 4, 2029
ToravasAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Akriti Pharmaceuticals Pvt. Ltd.India
The Cathay YSS Distributors Co., Inc.Importer: Aglobal Care, Inc.
DRP-8059-03
Mar 27, 2027
ToravasAtorvastatin (As Calcium)
40 mg Film-Coated TabletAlu / Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
The Cathay YSS Distributors Co., IncImporter: AMB HK Enterprises Inc.
DRP-14013-03
Jun 6, 2028
ToravasAtorvastatin (As Calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
The Cathay YSS Distributors Co., IncImporter: AMB HK Enterprises Inc.
DRP-14012-01
Jun 6, 2028
Tored-10Atorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 20's)
RxVAT-exempt
SAPPHIRE LIFESCIENCES PVT. LTDIndia
777 Red Pharma Inc.Importer: NELPA LIFESCIENCES, INC.
DRP-4470-01
Jun 13, 2028
Tored-20Atorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 20's)
RxVAT-exempt
Sapphire Lifesciences Pvt. Ltd.India
777 Red Pharma Inc.Importer: Nelpa Lifesciences, Inc.
DRP-5211-01
Mar 5, 2029
TORED-20Atorvastatin (as Calcium)
Film-Coated Tablet 20 mgAlu-Alu Blister Pack x 10’s (Box of 20’s, 30's, 60's, 90's & 100's)
RxVAT-exempt
Genom Biotech Pvt. Ltd.India
777 Red Pharma Inc.Importer: Nelpa Lifesciences, Inc.
DRP-5211-02
Apr 13, 2032
TorvastatinAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 40's Box of 40's
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
ST. RAPHAEL ARCHANGEL PHARMACEUTICAL PRODUCT DISTRIBUTION
DRP-5880-02
Sep 9, 2029
TorvastatinAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-6340-02
Sep 25, 2031
TorvastatinAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-6339-02
Sep 22, 2031
TorvastatinAtorvastatin (as calcium)
80 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-6341-02
Oct 27, 2031
Torzen-40Atorvastatin (as calcium trihydrate)
40 mg Film-Coated TabletAlu / Alu Blister Pack x 10's (Box of 100’s)
RxVAT-exempt
Healer's Lab (Unit II)India
Hale Medipoint Corp.Importer: Pharmakon Biotec Inc.
DRP-15961-03
Oct 4, 2029
Torzen-80Atorvastatin (as calcium trihydrate)
80 mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 100’s)
RxVAT-exempt
Healer's Lab (Unit II)India
Hale Medipoint Corp.Importer: Pharmakon Biotec Inc.
DRP-15406-01
Jul 3, 2029
TrazovastAtorvastatin (as calcium trihydrate)
80 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 100’s)
RxVAT-exempt
C.B. HEALTHCAREIndia
Pranish Inc.
DR-XY49806
Sep 24, 2031
TrovipriAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-10746
Nov 15, 2030
TrovipriAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-10747
Nov 15, 2031
TrovipriAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-10748
Nov 15, 2031
TrovipriAtorvastatin (as calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-10749
Nov 15, 2031
TruvastAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 100's
RxVAT-exempt
Flamingo Pharmaceuticals Ltd.India
Trumed PharmaceuticalsImporter: Hexagon Pharmaceuticals
DRP-2383-01
May 21, 2029
UnbrandedAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 100's
RxVAT-exempt
Ranbaxy (Malaysia) SDN. BHDMalaysia
Ritemed Phils., Inc.
DRP-1233
Feb 2, 2029
UnbrandedAtorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 30's
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
TGP Pharma Inc.Importer: Ambica International Corporation
DRP-3123-01
Jul 12, 2029
UnbrandedAtorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 30's
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Actimed, Inc.Importer: Ambica International Corporation
DRP-3123-03
Jul 12, 2029
UnbrandedAtorvastatin (As Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Alkem Laboratories CorporationImporter: Ambica International Corporation
DRP-3123-06
Jul 12, 2029
UnbrandedAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 30's
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Actimed, Inc.Trader: Innogen Pharmaceuticals, Inc.
DRP-5614-01
Mar 19, 2029
UnbrandedAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 30's
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Dr. Zen’s Research, Inc.Trader: Innogen Pharmaceuticals, Inc.
DRP-5614-04
Mar 19, 2029
UnbrandedAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 100's
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
Dyna Drug CorporationImporter: AMB HK ENTERPRISES INC.
DRP-11880-02
May 18, 2032
UnbrandedAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Ranbaxy (Malaysia) SDN. BHDMalaysia
Ritemed Phils., Inc.
DRP-1234
Feb 2, 2029
UnbrandedAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 24's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Dyna Drug Corporation
DR-XY38470
Sep 6, 2031
UnbrandedAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
—
DR-XY44901
Nov 9, 2030
UnbrandedAtorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
TGP Pharma Inc.
DRP-6540-02
Jul 8, 2029
UnbrandedAtorvastatin (as calcium)
40 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Ambica International Corporation
DRP-6922
Nov 22, 2031
Vasator 10Atorvastatin (as Calcium Trihydrate)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's; Box of 100's)
RxVAT-exempt
ACME Formulations Pvt. Ltd.India
GA2 Pharmaceutical Inc.Importer: Medinova Pharmaceutical Inc.
DRP-12225-03
Jul 12, 2027
Vascora 20Atorvastatin (as calcium trihydrate)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s, 60's and 100's)
RxVAT-exempt
Pinnacle Life Science Pvt. Ltd.India
Epione Lifecare Inc.Importer: Despina Pharma Inc.
DRP-15744-01
Sep 11, 2029
Vascora 40Atorvastatin (as calcium trihydrate)
40mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s, 60’s and 100's)
RxVAT-exempt
Pinnacle Life Science Pvt. Ltd.India
Epione Lifecare Inc.Importer: Despina Pharma Inc.
DRP-15743-01
Sep 11, 2029
VastaconAtorvastatin (as Calcium)
20 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 30's)
RxVAT-exempt
Bal Pharma LimitedIndia
D'Conner PharmaImporter: Pharmakon Biotec Inc.
DRP-5128-03
Feb 12, 2029
Vastalife-10Atorvastatin (As Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
Life and Health Source Pharmaceutical Distribution Co.Importer: AMB HK Enterprises Inc.
DRP-14015-02
Jun 6, 2028
Vastalife-20Atorvastatin (As Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
Life and Health Source Pharmaceutical Distribution Co.Importer: AMB HK Enterprises Inc.
DRP-14014-02
Jun 6, 2028
Vastalife-40Atorvastatin (As Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
Life and Health Source Pharmaceutical Distribution Co.Importer: AMB HK Enterprises Inc.
DRP-14013-02
Jun 6, 2028
VastamelAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 40's (Box of 40's, 120's & 200's); Alu/Opaque White PVC Blister Pack x 20's (Box of 100's); Alu/Opaque White PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Amiel Trading Inc.
DRP-5880-06
Sep 9, 2029
VastamelAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 20's (Box of 100's and 200's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Amiel Trading Inc.
DRP-6340-06
Oct 7, 2031
VastamelAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's and 200's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Amiel Trading Inc
DRP-6339-06
Oct 7, 2031
VastamelAtorvastatin (as Calcium)
80 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's and 200's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Amiel Trading Inc.
DRP-6341-06
Sep 29, 2031
VastanexAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Medisure Laboratories Pakistan (Pvt.) LimitedPakistan
D'Conner PharmaImporter: Accesspoint International Trading Inc.
DRP-6126-04
Feb 9, 2037
VASTATORAtorvastatin (as calcium)
40 mg Film-coated TabletALU / ALU BLISTER PACK X 8'S (BOX OF 40'S)
RxVAT-exempt
J.M. TOLMANN LABORATORIES INC.Philippines
CHMI PHARMA, INC.
DRP-3175-08
Jan 4, 2030
VASTIRED 80Atorvastatin (as calcium)
80 mg Film-Coated TabletAlu Foil Strip x 10’s (Box of 100's)
RxVAT-exempt
Sai Parenterals Ltd.#51 TSIIC Industrial Park Hyderabad-Warangal Highway Bhongir Telangana 508116 India
777 Red Pharma Inc.Importer: Nelpa Lifesciences, Inc.
DRP-10995-02
Nov 5, 2030
Vastmed 40Atorvastatin (as Calcium Trihydrate)
40 mg Film-Coated TabletAlu / Alu Blister Pack x 10's (Box of 100’s)
RxVAT-exempt
Healer's Lab (Unit II)India
Northmed Pharma and Medical Supplies DistributionImporter: Pharmakon Biotec Inc.
DRP-15961-04
Oct 4, 2029
VAZEMIAAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 50's and 100's)
RxVAT-exempt
BIOVEETA LABORATORIES PVT. LTD.India
JAERA PHARMA AND MEDICAL SUPPLIES TRADINGImporter: INTERMAC PHARMACEUTICAL INC.
DRP-5815-03
Sep 3, 2029
Vazi2rAtorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 40's Box of 40's, 120's & 200's); Alu/Opaque White PVC Blister Pack x 20's Box of 100's; Alu/Opaque White PVC Blister Pack x 10's Box of 30's and 100's
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
—
DRP-5880
Sep 9, 2029
VAzi2RAtorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 20's (Box of 100's and 200's); Alu/Opaque White PVC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
—
DRP-6340
Sep 11, 2030
VAZI2RAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's and 200's); Alu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories, Inc.Philippines
—
DRP-6339
Sep 11, 2030
Vazi2rAtorvastatin (as calcium)
80 mg Film-Coated TabletAlu PVC Blister Pack x 10's (Box of 30's, 50's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories IncPhilippines
—
DRP-16342
Feb 12, 2030
VAZI2RAtorvastatin (as Calcium)
80 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's and 200's); Alu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
—
DRP-6341
Sep 11, 2030
XantorAtorvastatin (as calcium trihydrate)
10 mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 100's)
RxVAT-exempt
Lek S.A.Poland
Importer: Sandoz Philippines Corporation
DRP-15501
Jul 29, 2029
XantorAtorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lek Pharmaceuticals D.D.Slovenia
Importer: Sandoz Philippines Corporation
DRP-2278
Aug 13, 2029
Xantor: Atorvastatin (as calcium trihydrate)
20 mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 100's)
RxVAT-exempt
Lek S.A.Poland
Importer: Sandoz Philippines Corporation
DRP-15500
Jul 29, 2029
XantorAtorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 100's
RxVAT-exempt
Lek Pharmaceuticals D.D.Slovenia
Importer: Sandoz Philippines Corporation
DRP-2272
Jul 3, 2029
XantorAtorvastatin (as calcium trihydrate)
40 mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 100's)
RxVAT-exempt
Lek S.A.Poland
Importer: Sandoz Philippines Corporation
DRP-15499
Jul 29, 2029
XantorAtorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lek Pharmaceuticals D.D.Slovenia
Importer: Sandoz Philippines Corporation
DRP-2279
Aug 13, 2029
XantorAtorvastatin (as calcium trihydrate)
80 mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 100's)
RxVAT-exempt
Lek S.A.Poland
Importer: Sandoz Philippines Corporation
DRP-15498
Jul 29, 2029
XantorAtorvastatin (as Calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lek Pharmaceuticals D.D.Slovenia
Importer: Sandoz Philippines Corporation
DRP-2273
Aug 13, 2029
XENTORATORVASTATIN ( AS CALCIUM)
40MG TABLET
RxVAT-exempt
—
Importer: STANGEN PHARMACEUTICALS PHILIPPINES INC
DRP-3517
Jan 26, 2027
Yorvas-10Atorvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Medisky PharmaceuticalsIndia
Aglobal Care, Inc.
DRP-15640
Aug 14, 2029
Yorvas-20Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Medisky PharmaceuticalsIndia
Aglobal Care, Inc.
DRP-15641
Aug 14, 2029
Yorvas-40Atorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Medisky PharmaceuticalsIndia
Aglobal Care, Inc.
DRP-15543
Aug 7, 2029
ZanvatorAtorvastatin (as Calcium Trihydrate)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 100's
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-4295-01
Mar 13, 2028
Zydusatorva 10Atorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's); Alu/Alu Blister Pack x 10's (Box of 10's) as Physician's Sample
RxVAT-exempt
Zydus Lifesciences LimitedIndia
Zydus Healthcare Philippines Inc.
DRP-12223
Jun 30, 2032
Zydusatorva 10Atorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's); Alu/Alu Blister Pack x 10's (Box of 10's as Physician Sample)
RxVAT-exempt
Zydus Lifesciences LimitedIndia
Zydus Healthcare Philippines, Inc.
DRP-7597
Jun 6, 2028
Zydusatorva 20Atorvastatin (As Calcium)
20 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's) Alu/Alu Blister Pack x 10's (Box of 10's) as Physician's Sample
RxVAT-exempt
Cadila Healthcare LimitedIndia
Zydus Healthcare Philippines Inc.
DRP-12222
Jun 30, 2027
Zydusatorva 80Atorvastatin (as Calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's); Alu/Alu Blister Pack x 8's (Box of 64's); Alu/Alu Blister Pack x 10's (Box of 10's) as Physician's Sample
RxVAT-exempt
Zydus Lifesciences LimitedIndia
Zydus Healthcare Philippines Inc.
DRP-12154
Jun 22, 2032
(no brand name)Atorvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack X 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories Inc.Philippines
Trader: Dr. Zen's Research, Inc.
DRP-18263
Jun 4, 2031
(no brand name)Atorvastatin (As Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack X 10'S
RxVAT-exempt
—
—
DRP-10747-06
Aug 25, 2037
(no brand name)Atorvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 3 blister packs x 10 tablets)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-13069
Nov 24, 2027
(no brand name)Atorvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack X 10's (Box of 80's)
RxVAT-exempt
Lloyd Laboratories Inc.Philippines
Trader: Dr. Zen's Research, Inc.
DRP-18264
Jun 4, 2031
(no brand name)Atorvastatin (as Calcium)
20 mg Film-Coated TabletBlister Pack x 10's (Box of 100's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
Watsons Personal Care Stores (Philippines), Inc.Importer: Philgen Pharmaceuticals Inc.
DRP-2778-04
Jul 14, 2027
(no brand name)Atorvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 3 blister packs x 10 tablets)
RxVAT-exempt
Stallion Laboratories Pvt., Ltd.India
Ambica International Corporation
DRP-13264
Jan 18, 2028
(no brand name)Atorvastatin (as Calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 80's)
RxVAT-exempt
Lloyd Laboratories Inc.Philippines
Trader: Dr. Zen's Research, Inc.
DRP-18316
Jun 10, 2031
(no brand name)Atorvastatin (As Calcium)
40mg Film-Coated TabletAlu/Alu Blister Pack x 10's
RxVAT-exempt
—
—
DRP-3109-04
Jul 12, 2029
(no brand name)Atorvastatin (as Calcium)
80 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 80's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Dr. Zen'S Research, Inc.
DRP-18265
Jun 4, 2031

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

United States (label)

Dosage forms and strengths (US label) US FDA label

3 DOSAGE FORMS AND STRENGTHS Tablets:

  • 10 mg of atorvastatin: white, elliptical, film-coated tablets debossed with “10” on one side and “VLE 155” on the other side
  • 20 mg of atorvastatin: white, elliptical, film-coated tablets debossed with “20” on one side and “VLE 156” on the other side
  • 40 mg of atorvastatin: white, elliptical, film-coated tablets debossed with “40” on one side and “VLE 157” on the other side
  • 80 mg of atorvastatin: white, elliptical, film-coated tablets debossed with “80” on one side and “VLE 158” on the other side Tablets: 10 mg; 20 mg; 40 mg; 80 mg of atorvastatin (3).

Warnings/Precautions

Warnings and precautions (US label) US FDA label

  • Myopathy and Rhabdomyolysis: Risk factors include age 65 years or greater, uncontrolled hypothyroidism, renal impairment, concomitant use with certain other drugs, and higher LIPITOR dosage. Discontinue LIPITOR if markedly elevated CK levels occur or myopathy is diagnosed or suspected. Temporarily discontinue LIPITOR in patients experiencing an acute or serious condition at high risk of developing renal failure secondary to rhabdomyolysis. Inform patients of the risk of myopathy and rhabdomyolysis when starting or increasing LIPITOR dosage. Instruct patients to promptly report unexplained muscle pain, tenderness, or weakness, particularly if accompanied by malaise or fever (2.5, 5.1, 7.1, 8.5, 8.6).
  • Immune-Mediated Necrotizing Myopathy (IMNM): Rare reports of IMNM, an autoimmune myopathy, have been reported with statin use. Discontinue LIPITOR if IMNM is suspected (5.2).
  • Hepatic Dysfunction: Increases in serum transaminases have occurred, some persistent. Rare reports of fatal and non-fatal hepatic failure have occurred. Consider testing liver enzymes before initiating therapy and as clinically indicated thereafter. If serious hepatic injury with clinical symptoms and/or hyperbilirubinemia or jaundice occurs, promptly discontinue LIPITOR (5.3).
5.1 Myopathy and Rhabdomyolysis

5.1 Myopathy and Rhabdomyolysis LIPITOR may cause myopathy (muscle pain, tenderness, or weakness associated with elevated creatine kinase [CK]) and rhabdomyolysis. Acute kidney injury secondary to myoglobinuria and rare fatalities have occurred as a result of rhabdomyolysis in patients treated with statins, including LIPITOR.

Risk Factors for Myopathy Risk factors for myopathy include age 65 years or greater, uncontrolled hypothyroidism, renal impairment, concomitant use with certain other drugs (including other lipid-lowering therapies), and higher LIPITOR dosage [see Drug Interactions (7.1) and Use in Specific Populations (8.5, 8.6)]. Steps to Prevent or Reduce the Risk of Myopathy and Rhabdomyolysis LIPITOR exposure may be increased by drug interactions due to inhibition of cytochrome P450 enzyme 3A4 (CYP3A4) and/or transporters (e.g., breast cancer resistant protein [BCRP], organic anion-transporting polypeptide [OATP1B1/OATP1B3] and P-glycoprotein [P-gp]), resulting in an increased risk of myopathy and rhabdomyolysis.

Concomitant use of cyclosporine, gemfibrozil, tipranavir plus ritonavir, or glecaprevir plus pibrentasvir with LIPITOR is not recommended. LIPITOR dosage modifications are recommended for patients taking certain anti-viral, azole antifungals, or macrolide antibiotic medications [see Dosage and Administration (2.5)]. Cases of myopathy/rhabdomyolysis have been reported with atorvastatin co-administered with lipid modifying doses (>1 gram/day) of niacin, fibrates, colchicine, and ledipasvir plus sofosbuvir [see Adverse Reactions (6.1)].

Consider if the benefit of use of these products outweighs the increased risk of myopathy and rhabdomyolysis [see Drug Interactions (7.1)]. Concomitant intake of large quantities, more than 1.2 liters daily, of grapefruit juice is not recommended in patients taking LIPITOR [see Drug Interactions (7.1)]. Discontinue LIPITOR if markedly elevated CK levels occur or if myopathy is either diagnosed or suspected.

Muscle symptoms and CK elevations may resolve if LIPITOR is discontinued. Temporarily discontinue LIPITOR in patients experiencing an acute or serious condition at high risk of developing renal failure secondary to rhabdomyolysis (e.g., sepsis; shock; severe hypovolemia; major surgery; trauma; severe metabolic, endocrine, or electrolyte disorders; or uncontrolled epilepsy).

Inform patients of the risk of myopathy and rhabdomyolysis when starting or increasing the LIPITOR dosage. Instruct patients to promptly report any unexplained muscle pain, tenderness or weakness, particularly if accompanied by malaise or fever.

5.2 Immune-Mediated Necrotizing Myopathy

5.2 Immune-Mediated Necrotizing Myopathy There have been rare reports of immune-mediated necrotizing myopathy (IMNM), an autoimmune myopathy, associated with statin use, including reports of recurrence when the same or a different statin was administered. IMNM is characterized by proximal muscle weakness and elevated serum creatine kinase that persists despite discontinuation of statin treatment; positive anti-HMG CoA reductase antibody; muscle biopsy showing necrotizing myopathy; and improvement with immunosuppressive agents.

Additional neuromuscular and serologic testing may be necessary. Treatment with immunosuppressive agents may be required. Discontinue LIPITOR if IMNM is suspected.

5.3 Hepatic Dysfunction

5.3 Hepatic Dysfunction Increases in serum transaminases have been reported with use of LIPITOR [see Adverse Reactions (6.1)]. In most cases, these changes appeared soon after initiation, were transient, were not accompanied by symptoms, and resolved or improved on continued therapy or after a brief interruption in therapy.

Persistent increases to more than three times the ULN in serum transaminases have occurred in approximately 0.7% of patients receiving LIPITOR in clinical trials. There have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins, including LIPITOR. Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury [see Use in Specific Populations (8.7)].

Consider liver enzyme testing before LIPITOR initiation and when clinically indicated thereafter. LIPITOR is contraindicated in patients with acute liver failure or decompensated cirrhosis [see Contraindications (4)]. If serious hepatic injury with clinical symptoms and/or hyperbilirubinemia or jaundice occurs, promptly discontinue LIPITOR.

5.4 Increases in HbA1c and Fasting Serum Glucose Levels

5.4 Increases in HbA1c and Fasting Serum Glucose Levels Increases in HbA1c and fasting serum glucose levels have been reported with statins, including LIPITOR. Optimize lifestyle measures, including regular exercise, maintaining a healthy body weight, and making healthy food choices.

5.5 Increased Risk of Hemorrhagic Stroke in Patients

5.5 Increased Risk of Hemorrhagic Stroke in Patients on LIPITOR 80 mg with Recent Hemorrhagic Stroke In a post-hoc analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial where 2,365 adult patients, without CHD who had a stroke or TIA within the preceding 6 months, were treated with LIPITOR 80 mg, a higher incidence of hemorrhagic stroke was seen in the LIPITOR 80 mg group compared to placebo (55, 2.3% LIPITOR vs. 33, 1.4% placebo; HR: 1.68, 95% CI: 1.09, 2.59; p=0.0168). The incidence of fatal hemorrhagic stroke was similar across treatment groups (17 vs. 18 for the atorvastatin and placebo groups, respectively).

The incidence of non-fatal hemorrhagic stroke was significantly higher in the LIPITOR group (38, 1.6%) as compared to the placebo group (16, 0.7%). Some baseline characteristics, including hemorrhagic and lacunar stroke on study entry, were associated with a higher incidence of hemorrhagic stroke in the LIPITOR group [see Adverse Reactions (6.1)].

Consider the risk/benefit of use of LIPITOR 80 mg in patients with recent hemorrhagic stroke.

Drug interactions

Drug or classSeverityEffectWhat to do
Cyclosporine, gemfibrozilAvoidHigher atorvastatin levels or additive myopathy risk.Combination not recommended.
Clarithromycin, itraconazoleAdjust or monitorHigher atorvastatin levels (CYP3A4/transporter inhibition).Do not exceed atorvastatin 20 mg; monitor for myopathy.
HIV and HCV protease inhibitors (e.g., tipranavir/ritonavir, glecaprevir/pibrentasvir)AvoidLarge rises in atorvastatin exposure.Tipranavir/ritonavir and glecaprevir/pibrentasvir: not recommended. Others: dose caps of 20 or 40 mg per the label.
RifampinAdjust or monitorMay lower atorvastatin levels.Give at the same time as atorvastatin.
DigoxinAdjust or monitorMay raise digoxin levels.Monitor digoxin.
Colchicine; fibrates (fenofibrate); niacin ≥1 g/dayAdjust or monitorMyopathy and rhabdomyolysis (higher risk with kidney impairment).Weigh benefit vs risk; monitor for muscle symptoms, especially at initiation and titration.

Severity scale (renalcarematters.com): Avoid: do not combine; Adjust or monitor: change the dose or monitor closely; Minor: usually no action.

renalcarematters.com, reviewed
Drug interactions (US label) US FDA label

  • See full prescribing information for details regarding concomitant use of LIPITOR with other drugs or grapefruit juice that increase the risk of myopathy and rhabdomyolysis (2.5, 7.1).
  • Rifampin: May reduce atorvastatin plasma concentrations. Administer simultaneously with LIPITOR (7.2).
  • Oral Contraceptives: May increase plasma levels of norethindrone and ethinyl estradiol; consider this effect when selecting an oral contraceptive (7.3).
  • Digoxin: May increase digoxin plasma levels; monitor patients appropriately (7.3).
7.1 Drug

7.1 Drug Interactions that may Increase the Risk of Myopathy and Rhabdomyolysis with LIPITOR LIPITOR is a substrate of CYP3A4 and transporters (e.g., OATP1B1/1B3, P-gp, or BCRP). LIPITOR plasma levels can be significantly increased with concomitant administration of inhibitors of CYP3A4 and transporters. Table 2 includes a list of drugs that may increase exposure to LIPITOR and may increase the risk of myopathy and rhabdomyolysis when used concomitantly and instructions for preventing or managing them [see Warnings and Precautions (5.1) and Clinical Pharmacology (12.3)].

Table 2: Drug Interactions that may Increase the Risk of Myopathy and Rhabdomyolysis with LIPITOR Cyclosporine or Gemfibrozil Clinical Impact: Atorvastatin plasma levels were significantly increased with concomitant administration of LIPITOR and cyclosporine, an inhibitor of CYP3A4 and OATP1B1 [see Clinical Pharmacology (12.3)]. Gemfibrozil may cause myopathy when given alone.

The risk of myopathy and rhabdomyolysis is increased with concomitant use of cyclosporine or gemfibrozil with LIPITOR. Intervention: Concomitant use of cyclosporine or gemfibrozil with LIPITOR is not recommended. Anti-Viral Medications Clinical Impact: Atorvastatin plasma levels were significantly increased with concomitant administration of LIPITOR with many anti-viral medications, which are inhibitors of CYP3A4 and/or transporters (e.g., BCRP, OATP1B1/1B3, P-gp, MRP2, and/or OAT2) [see Clinical Pharmacology (12.3)].

Cases of myopathy and rhabdomyolysis have been reported with concomitant use of ledipasvir plus sofosbuvir with LIPITOR. Intervention:

  • Concomitant use of tipranavir plus ritonavir or glecaprevir plus pibrentasvir with LIPITOR is not recommended.
  • In patients taking lopinavir plus ritonavir, or simeprevir, consider the risk/benefit of concomitant use with atorvastatin.
  • In patients taking saquinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir, fosamprenavir plus ritonavir, elbasvir plus grazoprevir or letermovir, do not exceed LIPITOR 20 mg.
  • In patients taking nelfinavir, do not exceed LIPITOR 40 mg [see Dosage and Administration (2.5)].
  • Consider the risk/benefit of concomitant use of ledipasvir plus sofosbuvir with LIPITOR.
  • Monitor all patients for signs and symptoms of myopathy particularly during initiation of therapy and during upward dose titration of either drug. Examples: Tipranavir plus ritonavir, glecaprevir plus pibrentasvir, lopinavir plus ritonavir, simeprevir, saquinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir, fosamprenavir plus ritonavir, elbasvir plus grazoprevir, letermovir, nelfinavir, and ledipasvir plus sofosbuvir. Select Azole Antifungals or Macrolide Antibiotics Clinical Impact: Atorvastatin plasma levels were significantly increased with concomitant administration of LIPITOR with select azole antifungals or macrolide antibiotics, due to inhibition of CYP3A4 and/or transporters [see Clinical Pharmacology (12.3)]. Intervention: In patients taking clarithromycin or itraconazole, do not exceed LIPITOR 20 mg [see Dosage and Administration (2.5)]. Consider the risk/benefit of concomitant use of other azole antifungals or macrolide antibiotics with LIPITOR. Monitor all patients for signs and symptoms of myopathy particularly during initiation of therapy and during upward dose titration of either drug. Examples: Erythromycin, clarithromycin, itraconazole, ketoconazole, posaconazole, and voriconazole. Niacin Clinical Impact: Cases of myopathy and rhabdomyolysis have been observed with concomitant use of lipid modifying dosages of niacin (≥1 gram/day niacin) with LIPITOR. Intervention: Consider if the benefit of using lipid modifying dosages of niacin concomitantly with LIPITOR outweighs the increased risk of myopathy and rhabdomyolysis. If concomitant use is decided, monitor patients for signs and symptoms of myopathy particularly during initiation of therapy and during upward dose titration of either drug. Fibrates (other than Gemfibrozil) Clinical Impact: Fibrates may cause myopathy when given alone. The risk of myopathy and rhabdomyolysis is increased with concomitant use of fibrates with LIPITOR. Intervention: Consider if the benefit of using fibrates concomitantly with LIPITOR outweighs the increased risk of myopathy and rhabdomyolysis. If concomitant use is decided, monitor patients for signs and symptoms of myopathy particularly during initiation of therapy and during upward dose titration of either drug. Colchicine Clinical Impact: Cases of myopathy and rhabdomyolysis have been reported with concomitant use of colchicine with LIPITOR. Intervention: Consider the risk/benefit of concomitant use of colchicine with LIPITOR. If concomitant use is decided, monitor patients for signs and symptoms of myopathy particularly during initiation of therapy and during upward dose titration of either drug. Grapefruit Juice Clinical Impact: Grapefruit juice consumption, especially excessive consumption, more than 1.2 liters/daily, can raise the plasma levels of atorvastatin and may increase the risk of myopathy and rhabdomyolysis. Intervention: Avoid intake of large quantities of grapefruit juice, more than 1.2 liters daily, when taking LIPITOR.
7.2 Drug

7.2 Drug Interactions that may Decrease Exposure to LIPITOR Table 3 presents drug interactions that may decrease exposure to LIPITOR and instructions for preventing or managing them. Table 3: Drug Interactions that may Decrease Exposure to LIPITOR Rifampin Clinical Impact: Concomitant administration of LIPITOR with rifampin, an inducer of cytochrome P450 3A4 and inhibitor of OATP1B1, can lead to variable reductions in plasma concentrations of atorvastatin.

Due to the dual interaction mechanism of rifampin, delayed administration of LIPITOR after administration of rifampin has been associated with a significant reduction in atorvastatin plasma concentrations. Intervention: Administer LIPITOR and rifampin simultaneously.

7.3 LIPITOR Effects on Other Drugs

7.3 LIPITOR Effects on Other Drugs Table 4 presents LIPITOR’s effect on other drugs and instructions for preventing or managing them. Table 4: LIPITOR Effects on Other Drugs Oral Contraceptives Clinical Impact: Co-administration of LIPITOR and an oral contraceptive increased plasma concentrations of norethindrone and ethinyl estradiol [see Clinical Pharmacology (12.3)].

Intervention: Consider this when selecting an oral contraceptive for patients taking LIPITOR. Digoxin Clinical Impact: When multiple doses of LIPITOR and digoxin were co-administered, steady state plasma digoxin concentrations increased [see Clinical Pharmacology (12.3)]. Intervention: Monitor patients taking digoxin appropriately.

Drug Interactions Atorvastatin is a substrate of the hepatic transporters, OATP1B1 and OATP1B3 transporter. Metabolites of atorvastatin are substrates of OATP1B1. Atorvastatin is also identified as a substrate of the efflux transporter BCRP, which may limit the intestinal absorption and biliary clearance of atorvastatin.

Table 5: Effect of Co-administered Drugs on the Pharmacokinetics of Atorvastatin Co-administered drug and dosage regimen Atorvastatin Dosage (mg) Ratio of AUC Represents ratio of treatments (co-administered drug plus atorvastatin vs. atorvastatin alone). Ratio of Cmax See Sections 5.1 and 7 for clinical significance. Cyclosporine 5.2 mg/kg/day, stable dose 10 mg QD Once daily for 28 days 8.69 10.66 Tipranavir 500 mg BID Twice daily /ritonavir 200 mg BID, 7 days 10 mg SD Single dosage 9.36 8.58 Glecaprevir 400 mg QD /pibrentasvir 120 mg QD, 7 days 10 mg QD for 7 days 8.28 22.00 Telaprevir 750 mg q8h Every 8 hours, 10 days 20 mg SD 7.88 10.60, The dose of saquinavir plus ritonavir in this study is not the clinically used dose.

The increase in atorvastatin exposure when used clinically is likely to be higher than what was observed in this study. Therefore, caution should be applied and the lowest dose necessary should be used. Saquinavir 400 mg BID /ritonavir 400 mg BID, 15 days 40 mg QD for 4 days 3.93 4.31 Elbasvir 50 mg QD /grazoprevir 200 mg QD, 13 days 10 mg SD 1.94 4.34 Simeprevir 150 mg QD, 10 days 40 mg SD 2.12 1.70 Clarithromycin 500 mg BID, 9 days 80 mg QD for 8 days 4.54 5.38 Darunavir 300 mg BID /ritonavir 100 mg BID, 9 days 10 mg QD for 4 days 3.45 2.25 Itraconazole 200 mg QD, 4 days 40 mg SD 3.32 1.20 Letermovir 480 mg QD, 10 days 20 mg SD 3.29 2.17 Fosamprenavir 700 mg BID /ritonavir 100 mg BID, 14 days 10 mg QD for 4 days 2.53 2.84 Fosamprenavir 1400 mg BID, 14 days 10 mg QD for 4 days 2.30 4.04 Nelfinavir 1250 mg BID, 14 days 10 mg QD for 28 days 1.74 2.22 Grapefruit Juice, 240 mL QD, Greater increases in AUC (ratio of AUC up to 2.5) and/or Cmax (ratio of Cmax up to 1.71) have been reported with excessive grapefruit consumption (≥ 750 mL-1.2 liters per day). 40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QID Four times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QD for 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74 Ratio based on a single sample taken 8-16 h post dose.

Maalox TC ® 30 mL QID, 17 days 10 mg QD for 15 days 0.66 0.67 Efavirenz 600 mg QD, 14 days 10 mg for 3 days 0.59 1.01 Rifampin 600 mg QD, 7 days (co‑administered) Due to the dual interaction mechanism of rifampin, simultaneous co-administration of atorvastatin with rifampin is recommended, as delayed administration of atorvastatin after administration of rifampin has been associated with a significant reduction in atorvastatin plasma concentrations. 40 mg SD 1.12 2.90 Rifampin 600 mg QD, 5 days (doses separated) 40 mg SD 0.20 0.60 Gemfibrozil 600 mg BID, 7 days 40 mg SD 1.35 1.00 Fenofibrate 160 mg QD, 7 days 40 mg SD 1.03 1.02 Boceprevir 800 mg TID Three times daily, 7 days 40 mg SD 2.32 2.66 Table 6: Effect of Atorvastatin on the Pharmacokinetics of Co-administered Drugs Atorvastatin Co-administered drug and dosage regimen Drug/Dosage (mg) Ratio of AUC Ratio of Cmax 80 mg QD Once daily for 15 days Antipyrine, 600 mg SD Single dosage 1.03 0.89 80 mg QD for 10 days See Section 7 for clinical significance. Digoxin 0.25 mg QD, 20 days 1.15 1.20 40 mg QD for 22 days Oral contraceptive QD, 2 months - norethindrone 1 mg - ethinyl estradiol 35 µg 1.28 1.19 1.23 1.30 10 mg SD Tipranavir 500 mg BID Twice daily /ritonavir 200 mg BID, 7 days 1.08 0.96 10 mg QD for 4 days Fosamprenavir 1400 mg BID, 14 days 0.73 0.82 10 mg QD for 4 days Fosamprenavir 700 mg BID /ritonavir 100 mg BID, 14 days 0.99 0.94 LIPITOR had no clinically significant effect on prothrombin time when administered to patients receiving chronic warfarin treatment.

Metabolism and transporters (CYP, P-gp, OATP; US label) US FDA label

Drug Interactions Atorvastatin is a substrate of the hepatic transporters, OATP1B1 and OATP1B3 transporter.

Metabolites of atorvastatin are substrates of OATP1B1.

Atorvastatin is also identified as a substrate of the efflux transporter BCRP, which may limit the intestinal absorption and biliary clearance of atorvastatin.

Administer simultaneously with LIPITOR ( 7.2 ). • Oral Contraceptives: May increase plasma levels of norethindrone and ethinyl estradiol; consider this effect when selecting an oral contraceptive ( 7.3 ). • Digoxin: May increase digoxin plasma levels; monitor patients appropriately ( 7.3 ). 7.1 Drug Interactions that may Increase the Risk of Myopathy and Rhabdomyolysis with LIPITOR LIPITOR is a substrate of CYP3A4 and transporters (e.g., OATP1B1/1B3, P-gp, or BCRP).

LIPITOR plasma levels can be significantly increased with concomitant administration of inhibitors of CYP3A4 and transporters.

Table 2: Drug Interactions that may Increase the Risk of Myopathy and Rhabdomyolysis with LIPITOR Cyclosporine or Gemfibrozil Clinical Impact: Atorvastatin plasma levels were significantly increased with concomitant administration of LIPITOR and cyclosporine, an inhibitor of CYP3A4 and OATP1B1 [see Clinical Pharmacology (12.3) ] .

Anti-Viral Medications Clinical Impact: Atorvastatin plasma levels were significantly increased with concomitant administration of LIPITOR with many anti-viral medications, which are inhibitors of CYP3A4 and/or transporters (e.g., BCRP, OATP1B1/1B3, P-gp, MRP2, and/or OAT2) [see Clinical Pharmacology (12.3) ] .

Select Azole Antifungals or Macrolide Antibiotics Clinical Impact: Atorvastatin plasma levels were significantly increased with concomitant administration of LIPITOR with select azole antifungals or macrolide antibiotics, due to inhibition of CYP3A4 and/or transporters [see Clinical Pharmacology (12.3) ] .

Adverse reactions

Common

  • Nasopharyngitis (8.3%)
  • Arthralgia (6.9%)
  • Diarrhea (6.8%)
  • Pain in extremity (6.0%)
  • Urinary tract infection (5.7%)
  • Dyspepsia (4.7%)
  • Nausea (4.0%)

Serious

  • Myopathy and rhabdomyolysis
  • Immune-mediated necrotizing myopathy
  • Hepatic dysfunction
  • Rises in HbA1c and fasting glucose
  • Hemorrhagic stroke risk with 80 mg after recent stroke or TIA
renalcarematters.com, reviewed
Adverse reactions (US label) US FDA label

The following important adverse reactions are described below and elsewhere in the labeling:

  • Myopathy and Rhabdomyolysis [see Warnings and Precautions (5.1)]
  • Immune-Mediated Necrotizing Myopathy [see Warnings and Precautions (5.2)]
  • Hepatic Dysfunction [see Warnings and Precautions (5.3)]
  • Increases in HbA1c and Fasting Serum Glucose Levels [see Warnings and Precautions (5.4)] Most common adverse reactions (incidence ≥5%) are nasopharyngitis, arthralgia, diarrhea, pain in extremity, and urinary tract infection (6.1). To report SUSPECTED ADVERSE REACTIONS, contact Viatris at 1-877-446-3679 (1-877-4-INFO-RX) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
6.1 Clinical Trials Experience

6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, the adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. In the LIPITOR placebo-controlled clinical trial database of 16,066 patients (8755 LIPITOR vs. 7,311 placebo; age range 10-93 years, 39% female, 91% White, 3% Black or African American, 2% Asian, 4% other) with a median treatment duration of 53 weeks, the most common adverse reactions in patients treated with LIPITOR that led to treatment discontinuation and occurred at a rate greater than placebo were: myalgia (0.7%), diarrhea (0.5%), nausea (0.4%), alanine aminotransferase increase (0.4%), and hepatic enzyme increase (0.4%).

Table 1 summarizes adverse reactions reported in ≥ 2% and at a rate greater than placebo in patients treated with LIPITOR (n=8,755), from seventeen placebo-controlled trials. Table 1: Adverse Reactions Occurring in ≥ 2% in Patients LIPITOR-Treated with any Dose and Greater than Placebo Adverse Reaction % Placebo N=7,311 % 10 mg N=3,908 % 20 mg N=188 % 40 mg N=604 % 80 mg N=4,055 % Any dose N=8,755 Nasopharyngitis 8.2 12.9 5.3 7.0 4.2 8.3 Arthralgia 6.5 8.9 11.7 10.6 4.3

6.9 Diarrhea 6

6.9 Diarrhea 6.3 7.3 6.4 14.1 5.2

6.8 Pain

6.8 Pain in extremity 5.9 8.5 3.7 9.3 3.1

6.0 Urinary

6.0 Urinary tract infection 5.6 6.9 6.4 8.0 4.1 5.7 Dyspepsia 4.3 5.9 3.2 6.0 3.3 4.7 Nausea 3.5 3.7 3.7 7.1 3.8 4.0 Musculoskeletal pain 3.6 5.2 3.2 5.1 2.3 3.8 Muscle spasms 3.0 4.6 4.8 5.1 2.4 3.6 Myalgia 3.1 3.6 5.9 8.4 2.7 3.5 Insomnia 2.9 2.8 1.1 5.3 2.8 3.0 Pharyngolaryngeal pain 2.1 3.9 1.6 2.8 0.7 2.3 Other adverse reactions reported in placebo-controlled trials include: Body as a Whole: malaise, pyrexia Digestive System: abdominal discomfort, eructation, flatulence, hepatitis, cholestasis Musculoskeletal System: musculoskeletal pain, muscle fatigue, neck pain, joint swelling Metabolic and Nutritional System: transaminases increase, liver function test abnormal, blood alkaline phosphatase increase, creatine phosphokinase increase, hyperglycemia Nervous System: nightmare Respiratory System: epistaxis Skin and Appendages: urticaria Special Senses: vision blurred, tinnitus Urogenital System: white blood cells urine positive Elevations in Liver Enzyme Tests Persistent elevations in serum transaminases, defined as more than 3 times the ULN and occurring on 2 or more occasions, occurred in 0.7% of patients who received LIPITOR in clinical trials. The incidence of these abnormalities was 0.2%, 0.2%, 0.6%, and 2.3% for 10, 20, 40, and 80 mg, respectively.

One patient in clinical trials developed jaundice. Increases in liver enzyme tests in other patients were not associated with jaundice or other clinical signs or symptoms. Upon dose reduction, drug interruption, or discontinuation, transaminase levels returned to or near pretreatment levels without sequelae. Eighteen of 30 patients with persistent liver enzyme elevations continued treatment with a reduced dose of LIPITOR.

Treating to New Targets Study (TNT) In TNT, [see Clinical Studies (14.1)] 10,001 patients (age range 29-78 years, 19% female; 94% White, 3% Black or African American, 1% Asian, 2% other) with clinically evident CHD were treated with LIPITOR 10 mg daily (n=5006) or LIPITOR 80 mg daily (n=4995). In the high-dose LIPITOR group, there were more patients with serious adverse reactions (1.8%) and discontinuations due to adverse reactions (9.9%) as compared to the low-dose group (1.4%; 8.1%, respectively) during a median follow-up of 4.9 years.

Persistent transaminase elevations (≥3 x ULN twice within 4-10 days) occurred in 1.3% of individuals with LIPITOR 80 mg and in 0.2% of individuals with LIPITOR 10 mg. Elevations of CK (≥ 10 x ULN) were higher in the high-dose LIPITOR group (0.3%) compared to the low-dose LIPITOR group (0.1%). Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) In SPARCL, 4,731 patients (age range 21-92 years, 40% female; 93% White, 3% Black or African American, 1% Asian, 3% other) without clinically evident CHD but with a stroke or transient ischemic attack (TIA) within the previous 6 months were treated with LIPITOR 80 mg (n=2365) or placebo (n=2366) for a median follow-up of 4.9 years.

There was a higher incidence of persistent hepatic transaminase elevations (≥ 3 x ULN twice within 4-10 days) in the LIPITOR group (0.9%) compared to placebo (0.1%). Elevations of CK (>10 x ULN) were rare, but were higher in the LIPITOR group (0.1%) compared to placebo (0.0%). Diabetes was reported as an adverse reaction in 6.1% of subjects in the LIPITOR group and 3.8% of subjects in the placebo group.

In a post-hoc analysis, LIPITOR 80 mg reduced the incidence of ischemic stroke (9.2% vs. 11.6%) and increased the incidence of hemorrhagic stroke (2.3% vs. 1.4%) compared to placebo. The incidence of fatal hemorrhagic stroke was similar between groups (17 LIPITOR vs. 18 placebo). The incidence of non-fatal hemorrhagic strokes was significantly greater in the LIPITOR group (38 non-fatal hemorrhagic strokes) as compared to the placebo group (16 non-fatal hemorrhagic strokes).

Patients who entered the trial with a hemorrhagic stroke appeared to be at increased risk for hemorrhagic stroke (16% LIPITOR vs. 4% placebo). Adverse Reactions from Clinical Studies of LIPITOR in Pediatric Patients with HeFH In a 26-week controlled study in pediatric patients with HeFH (ages 10 years to 17 years) (n=140, 31% female; 92% White, 1.6% Black or African American, 1.6% Asian, 4.8% other), the safety and tolerability profile of LIPITOR 10 to 20 mg daily, as an adjunct to diet to reduce total cholesterol, LDL-C, and apo B levels, was generally similar to that of placebo [see Use in Specific Populations (8.4) and Clinical Studies (14.6)].

6.2 Postmarketing Experience

6.2 Postmarketing Experience The following adverse reactions have been identified during post-approval use of LIPITOR. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Gastrointestinal Disorders: pancreatitis General Disorders: fatigue Hepatobiliary Disorders: fatal and non-fatal hepatic failure Immune System Disorders: anaphylaxis Injury: tendon rupture Musculoskeletal and Connective Tissue Disorders: rhabdomyolysis, myositis.

There have been rare reports of immune-mediated necrotizing myopathy associated with statin use. Nervous System Disorders: dizziness, peripheral neuropathy. There have been rare reports of cognitive impairment (e.g., memory loss, forgetfulness, amnesia, memory impairment, confusion) associated with the use of all statins.

Cognitive impairment was generally nonserious, and reversible upon statin discontinuation, with variable times to symptom onset (1 day to years) and symptom resolution (median of 3 weeks). There have been rare reports of new-onset or exacerbation of myasthenia gravis, including ocular myasthenia, and reports of recurrence when the same or a different statin was administered.

Psychiatric Disorders: depression Respiratory Disorders: interstitial lung disease Skin and Subcutaneous Tissue Disorders: angioneurotic edema, bullous rashes (including erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis)

Adverse reaction frequency tables (US label) US FDA label
Table 1: Adverse Reactions Occurring in ≥ 2% in Patients LIPITOR-Treated with any Dose and Greater than Placebo
Adverse Reaction% Placebo N=7,311% 10 mg N=3,908% 20 mg N=188 % 40 mg N=604 % 80 mg N=4,055% Any dose N=8,755
Nasopharyngitis8.212.95.37.04.28.3
Arthralgia6.58.911.710.64.36.9
Diarrhea6.37.36.414.15.26.8
Pain in extremity5.98.53.79.33.16.0
Urinary tract infection 5.66.96.48.04.15.7
Dyspepsia4.35.93.26.03.34.7
Nausea3.53.73.77.13.84.0
Musculoskeletal pain3.65.23.25.12.33.8
Muscle spasms3.04.64.85.12.43.6
Myalgia3.13.65.98.42.73.5
Insomnia2.92.81.15.32.83.0
Pharyngolaryngeal pain2.13.91.62.80.72.3

Monitoring parameters

  • Muscle symptoms (myopathy, rhabdomyolysis); renal impairment is a risk factor (label). Kidney
  • LDL-C as early as 4 weeks after starting or changing the dose
  • Muscle symptoms, especially when starting, titrating or adding an interacting drug
  • Liver enzymes when clinically indicated
renalcarematters.com, reviewed

Pregnancy considerations

Pregnancy (US label) US FDA label

8.1 Pregnancy Risk Summary Discontinue LIPITOR when pregnancy is recognized. Alternatively, consider the ongoing therapeutic needs of the individual patient. LIPITOR decreases synthesis of cholesterol and possibly other biologically active substances derived from cholesterol; therefore, LIPITOR may cause fetal harm when administered to pregnant patients based on the mechanism of action [see Clinical Pharmacology (12.1)].

In addition, treatment of hyperlipidemia is not generally necessary during pregnancy. Atherosclerosis is a chronic process and the discontinuation of lipid-lowering drugs during pregnancy should have little impact on the outcome of long-term therapy of primary hyperlipidemia for most patients. Available data from case series and prospective and retrospective observational cohort studies over decades of use with statins in pregnant women have not identified a drug-associated risk of major congenital malformations.

Published data from prospective and retrospective observational cohort studies with LIPITOR use in pregnant women are insufficient to determine if there is a drug-associated risk of miscarriage (see Data). In animal reproduction studies, no adverse developmental effects were observed in pregnant rats or rabbits orally administered atorvastatin at doses that resulted in up to 30 and 20 times, respectively, the human exposure at the maximum recommended human dose (MRHD) of 80 mg, based on body surface area (mg/m 2).

In rats administered atorvastatin during gestation and lactation, decreased postnatal growth and development delay were observed at doses ≥ 6 times the MRHD (see Data). The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively.

Data Human Data A Medicaid cohort linkage study of 1,152 statin-exposed pregnant women compared to 886,996 controls did not find a significant teratogenic effect from maternal use of statins in the first trimester of pregnancy, after adjusting for potential confounders – including maternal age, diabetes mellitus, hypertension, obesity, and alcohol and tobacco use – using propensity score-based methods. The relative risk of congenital malformations between the group with statin use and the group with no statin use in the first trimester was 1.07 (95% confidence interval 0.85 to 1.37) after controlling for confounders, particularly pre-existing diabetes mellitus.

There were also no statistically significant increases in any of the organ-specific malformations assessed after accounting for confounders. In the majority of pregnancies, statin treatment was initiated prior to pregnancy and was discontinued at some point in the first trimester when pregnancy was identified. Study limitations include reliance on physician coding to define the presence of a malformation, lack of control for certain confounders such as body mass index, use of prescription dispensing as verification for the use of a statin, and lack of information on non-live births.

Animal Data Atorvastatin was administered to pregnant rats and rabbits during organogenesis at oral doses up to 300 mg/kg/day and 100 mg/kg/day, respectively. Atorvastatin was not teratogenic in rats at doses up to 300 mg/kg/day or in rabbits at doses up to 100 mg/kg/day. These doses resulted in multiples of about 30 times (rat) or 20 times (rabbit) the human exposure at the MRHD based on surface area (mg/m2).

In rats, the maternally toxic dose of 300 mg/kg resulted in increased post-implantation loss and decreased fetal body weight. At the maternally toxic doses of 50 and 100 mg/kg/day in rabbits, there was increased post-implantation loss, and at 100 mg/kg/day fetal body weights were decreased. In a study in pregnant rats administered 20, 100, or 225 mg/kg/day from gestation day 7 through to lactation day 20 (weaning), there was decreased survival at birth, postnatal day 4, weaning, and post-weaning in pups of mothers dosed with 225 mg/kg/day, a dose at which maternal toxicity was observed.

Pup body weight was decreased through postnatal day 21 at 100 mg/kg/day, and through postnatal day 91 at 225 mg/kg/day. Pup development was delayed (rotorod performance at 100 mg/kg/day and acoustic startle at 225 mg/kg/day; pinnae detachment and eye-opening at 225 mg/kg/day). These doses correspond to 6 times (100 mg/kg) and 22 times (225 mg/kg) the human exposure at the MRHD, based on AUC.

Atorvastatin crosses the rat placenta and reaches a level in fetal liver equivalent to that of maternal plasma.

Mechanism of action

12.1 Mechanism of Action LIPITOR is a selective, competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methylglutaryl-coenzyme A to mevalonate, a precursor of sterols, including cholesterol. In animal models, LIPITOR lowers plasma cholesterol and lipoprotein levels by inhibiting HMG-CoA reductase and cholesterol synthesis in the liver and by increasing the number of hepatic LDL receptors on the cell surface to enhance uptake and catabolism of LDL; LIPITOR also reduces LDL production and the number of LDL particles.

US FDA label

Pharmacodynamics

Pharmacodynamics (US label) US FDA label

12.2 Pharmacodynamics LIPITOR, as well as some of its metabolites, are pharmacologically active in humans. The liver is the primary site of action and the principal site of cholesterol synthesis and LDL clearance. Drug dosage, rather than systemic drug concentration, correlates better with LDL-C reduction. Individualization of drug dosage should be based on therapeutic response [see Dosage and Administration (2)].

Pharmacokinetics

Key PK parameters

BioavailabilityAbout 14% (parent); about 30% HMG-CoA reductase inhibitory activity
Time to peak1 to 2 hours
Half-lifeAbout 14 hours (inhibitory activity 20 to 30 hours)
Half-life in kidney failure (ESKD) kidneyNot studied in ESRD (label).
Volume of distributionAbout 381 L
Protein binding≥98%
Metabolism (CYP, transporters)Extensive, CYP3A4; substrate of OATP1B1/1B3, P-gp and BCRP
Active metabolitesOrtho- and parahydroxylated metabolites (about 70% of circulating inhibitory activity)
Renal excretion kidneyLess than 2% in urine; mainly biliary
Dialyzability kidneyNot expected to be significantly removed (highly protein bound; label).
renalcarematters.com, reviewed
Half-life and elimination (verbatim, US label)

Excretion LIPITOR and its metabolites are eliminated primarily in bile following hepatic and/or extra-hepatic metabolism; however, the drug does not appear to undergo enterohepatic recirculation.

Mean plasma elimination half-life of LIPITOR in humans is approximately 14 hours, but the half-life of inhibitory activity for HMG-CoA reductase is 20 to 30 hours due to the contribution of active metabolites.

Pharmacokinetics (US label) US FDA label

12.3 Pharmacokinetics Absorption LIPITOR is rapidly absorbed after oral administration; maximum plasma concentrations occur within 1 to 2 hours. Extent of absorption increases in proportion to LIPITOR dose. The absolute bioavailability of atorvastatin (parent drug) is approximately 14% and the systemic availability of HMG-CoA reductase inhibitory activity is approximately 30%.

The low systemic availability is attributed to presystemic clearance in gastrointestinal mucosa and/or hepatic first-pass metabolism. Although food decreases the rate and extent of drug absorption by approximately 25% and 9%, respectively, as assessed by Cmax and AUC, LDL-C reduction is similar whether LIPITOR is given with or without food.

Plasma LIPITOR concentrations are lower (approximately 30% for Cmax and AUC) following evening drug administration compared with morning. However, LDL-C reduction is the same regardless of the time of day of drug administration. Distribution Mean volume of distribution of LIPITOR is approximately 381 liters. LIPITOR is ≥98% bound to plasma proteins.

A blood/plasma ratio of approximately 0.25 indicates poor drug penetration into red blood cells. Elimination Metabolism LIPITOR is extensively metabolized to ortho- and parahydroxylated derivatives and various beta-oxidation products. In vitro inhibition of HMG-CoA reductase by ortho- and parahydroxylated metabolites is equivalent to that of LIPITOR.

Approximately 70% of circulating inhibitory activity for HMG-CoA reductase is attributed to active metabolites. In vitro studies suggest the importance of LIPITOR metabolism by cytochrome P450 3A4, consistent with increased plasma concentrations of LIPITOR in humans following co-administration with erythromycin, a known inhibitor of this isozyme [see Drug Interactions (7.1)].

In animals, the ortho-hydroxy metabolite undergoes further glucuronidation. Excretion LIPITOR and its metabolites are eliminated primarily in bile following hepatic and/or extra-hepatic metabolism; however, the drug does not appear to undergo enterohepatic recirculation. Mean plasma elimination half-life of LIPITOR in humans is approximately 14 hours, but the half-life of inhibitory activity for HMG-CoA reductase is 20 to 30 hours due to the contribution of active metabolites.

Less than 2% of a dose of LIPITOR is recovered in urine following oral administration. Specific Populations Geriatric Plasma concentrations of LIPITOR are higher (approximately 40% for Cmax and 30% for AUC) in healthy elderly subjects (age ≥65 years) than in young adults. Pediatric Apparent oral clearance of atorvastatin in pediatric subjects appeared similar to that of adults when scaled allometrically by body weight as the body weight was the only significant covariate in atorvastatin population PK model with data including pediatric HeFH patients (ages 10 years to 17 years of age, n=29) in an open-label, 8-week study.

Gender Plasma concentrations of LIPITOR in females differ from those in males (approximately 20% higher for Cmax and 10% lower for AUC); however, there is no clinically significant difference in LDL-C reduction with LIPITOR between males and females. Renal Impairment Renal disease has no influence on the plasma concentrations or LDL-C reduction of LIPITOR [see Use in Specific Populations (8.6)].

While studies have not been conducted in patients with end-stage renal disease, hemodialysis is not expected to significantly enhance clearance of LIPITOR since the drug is extensively bound to plasma proteins. Hepatic Impairment In patients with chronic alcoholic liver disease, plasma concentrations of LIPITOR are markedly increased.

Cmax and AUC are each 4-fold greater in patients with Childs-Pugh A disease. Cmax and AUC are approximately 16-fold and 11-fold increased, respectively, in patients with Childs-Pugh B disease [see Use in Specific Populations (8.7)]. Drug Interactions Atorvastatin is a substrate of the hepatic transporters, OATP1B1 and OATP1B3 transporter.

Metabolites of atorvastatin are substrates of OATP1B1. Atorvastatin is also identified as a substrate of the efflux transporter BCRP, which may limit the intestinal absorption and biliary clearance of atorvastatin. Table 5: Effect of Co-administered Drugs on the Pharmacokinetics of Atorvastatin Co-administered drug and dosage regimen Atorvastatin Dosage (mg) Ratio of AUC Represents ratio of treatments (co-administered drug plus atorvastatin vs. atorvastatin alone).

Ratio of Cmax See Sections 5.1 and 7 for clinical significance. Cyclosporine 5.2 mg/kg/day, stable dose 10 mg QD Once daily for 28 days 8.69 10.66 Tipranavir 500 mg BID Twice daily /ritonavir 200 mg BID, 7 days 10 mg SD Single dosage 9.36 8.58 Glecaprevir 400 mg QD /pibrentasvir 120 mg QD, 7 days 10 mg QD for 7 days 8.28 22.00 Telaprevir 750 mg q8h Every 8 hours, 10 days 20 mg SD 7.88 10.60, The dose of saquinavir plus ritonavir in this study is not the clinically used dose.

The increase in atorvastatin exposure when used clinically is likely to be higher than what was observed in this study. Therefore, caution should be applied and the lowest dose necessary should be used. Saquinavir 400 mg BID /ritonavir 400 mg BID, 15 days 40 mg QD for 4 days 3.93 4.31 Elbasvir 50 mg QD /grazoprevir 200 mg QD, 13 days 10 mg SD 1.94 4.34 Simeprevir 150 mg QD, 10 days 40 mg SD 2.12 1.70 Clarithromycin 500 mg BID, 9 days 80 mg QD for 8 days 4.54 5.38 Darunavir 300 mg BID /ritonavir 100 mg BID, 9 days 10 mg QD for 4 days 3.45 2.25 Itraconazole 200 mg QD, 4 days 40 mg SD 3.32 1.20 Letermovir 480 mg QD, 10 days 20 mg SD 3.29 2.17 Fosamprenavir 700 mg BID /ritonavir 100 mg BID, 14 days 10 mg QD for 4 days 2.53 2.84 Fosamprenavir 1400 mg BID, 14 days 10 mg QD for 4 days 2.30 4.04 Nelfinavir 1250 mg BID, 14 days 10 mg QD for 28 days 1.74 2.22 Grapefruit Juice, 240 mL QD, Greater increases in AUC (ratio of AUC up to 2.5) and/or Cmax (ratio of Cmax up to 1.71) have been reported with excessive grapefruit consumption (≥ 750 mL-1.2 liters per day). 40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QID Four times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QD for 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74 Ratio based on a single sample taken 8-16 h post dose.

Maalox TC ® 30 mL QID, 17 days 10 mg QD for 15 days 0.66 0.67 Efavirenz 600 mg QD, 14 days 10 mg for 3 days 0.59 1.01 Rifampin 600 mg QD, 7 days (co‑administered) Due to the dual interaction mechanism of rifampin, simultaneous co-administration of atorvastatin with rifampin is recommended, as delayed administration of atorvastatin after administration of rifampin has been associated with a significant reduction in atorvastatin plasma concentrations. 40 mg SD 1.12 2.90 Rifampin 600 mg QD, 5 days (doses separated) 40 mg SD 0.20 0.60 Gemfibrozil 600 mg BID, 7 days 40 mg SD 1.35 1.00 Fenofibrate 160 mg QD, 7 days 40 mg SD 1.03 1.02 Boceprevir 800 mg TID Three times daily, 7 days 40 mg SD 2.32 2.66 Table 6: Effect of Atorvastatin on the Pharmacokinetics of Co-administered Drugs Atorvastatin Co-administered drug and dosage regimen Drug/Dosage (mg) Ratio of AUC Ratio of Cmax 80 mg QD Once daily for 15 days Antipyrine, 600 mg SD Single dosage 1.03 0.89 80 mg QD for 10 days See Section 7 for clinical significance. Digoxin 0.25 mg QD, 20 days 1.15 1.20 40 mg QD for 22 days Oral contraceptive QD, 2 months - norethindrone 1 mg - ethinyl estradiol 35 µg 1.28 1.19 1.23 1.30 10 mg SD Tipranavir 500 mg BID Twice daily /ritonavir 200 mg BID, 7 days 1.08 0.96 10 mg QD for 4 days Fosamprenavir 1400 mg BID, 14 days 0.73 0.82 10 mg QD for 4 days Fosamprenavir 700 mg BID /ritonavir 100 mg BID, 14 days 0.99 0.94 LIPITOR had no clinically significant effect on prothrombin time when administered to patients receiving chronic warfarin treatment.

Formulary and pricing (Philippines)

Government price references

PreparationPrice (PHP)UnitType
Atorvastatin 10 mg Tablet₱1.32–₱9.00Reference ₱4.86per tabletDPRI procurement range
Atorvastatin 20 mg Tablet₱1.00–₱10.61Reference ₱4.98per tabletDPRI procurement range
Atorvastatin 40 mg Tablet₱1.88–₱19.00Reference ₱9.24per tabletDPRI procurement range
Atorvastatin 80 mg Tablet₱7.05–₱23.30Reference ₱19.18per tabletDPRI procurement range
10 mg (as calcium) tablet₱10.00per tabletPhilHealth GAMOT fixed fee
20 mg (as calcium) tablet₱12.25per tabletPhilHealth GAMOT fixed fee
40 mg (as calcium) tablet₱17.25per tabletPhilHealth GAMOT fixed fee
80 mg (as calcium) tablet₱25.00per tabletPhilHealth GAMOT fixed fee

PhilHealth GAMOT fixed fee paid to the accredited GAMOT pharmacy per unit dispensed Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)

These are government procurement and reimbursement references, not retail prices. Sources:

Formulary and coverage

Philippine National FormularyListed as Atorvastatin calcium
PNF listingOral: 10 mg, 20 mg, 40 mg and 80 mg tablet
PhilHealth GAMOTYes (listed since July 28, 2025)

Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. Lipitor · Viatris Specialty LLC [US FDA-approved label, version 8, April 15, 2024]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a60cc18b-0631-4cf0-b021-9f52224ece65
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  3. PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
  4. PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
  5. PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
  6. DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
  7. Viatris Specialty LLC. (2024). Lipitor (atorvastatin calcium) [Prescribing information; US FDA-approved label, NDA020702, set ID a60cc18b-0631-4cf0-b021-9f52224ece65, version effective April 15, 2024]. DailyMed, U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a60cc18b-0631-4cf0-b021-9f52224ece65
  8. Wanner, C., & Tonelli, M. (2014). KDIGO clinical practice guideline for lipid management in CKD: Summary of recommendation statements and clinical approach to the patient. Kidney International, 85(6), 1303–1309. https://doi.org/10.1038/ki.2014.31
  9. Schwartz, G. J., Muñoz, A., Schneider, M. F., Mak, R. H., Kaskel, F., Warady, B. A., & Furth, S. L. (2009). New equations to estimate GFR in children with CKD. Journal of the American Society of Nephrology, 20(3), 629–637. https://doi.org/10.1681/ASN.2008030287

renalcarematters.com content: Kidney and pediatric dosing: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 16, 2026. Dosing, interaction, adverse-effect and monitoring summary: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 16, 2026.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .